The PenCraft Awards committee is proud to have B. Alan Bourgeois, Founder of Texas Authors as a guest speaker at the 2nd Annual PenCraft Awards ceremony being held in Lumberton, Texas, November 10, 2018

BEAUMONT, Texas (PRWEB) November 01, 2018

The PenCraft Awards committee is proud to have B. Alan Bourgeois, Founder of Texas Authors as a guest speaker at the 2nd Annual PenCraft Awards ceremony being held in Lumberton, Texas, November 10, 2018,. Back in 2011, Bourgeois founded Texas Authors, an organization whose goal is to help Texas Authors market and sell their books. It was conceived when Bourgeois realized Texas had lots of talented writers but lacked any organization that focused on assisting them in marketing and selling their work. Since its 2011 inception, Alan has continued to add new programs and benefits to the organization.

Texas Authors; programs and offerings benefit Texas authors who want to succeed in the difficult book market. A few of these offerings include programs such as DEAR Texas, Inc. and Texas Authors Institute of History, Inc., access to Book Festival events, annual book contests, short story contests, getting authors into Barnes & Noble, Krogers, Sam's Club and other stores to sell their books, an annual Authors Marketing (http://Authors.Marketing) event and many other programs.

Alan is passionate about helping authors and his address will provide interesting and exciting messages for the guests at the 2nd Annual PenCraft awards. His organizations has also been gracious in providing 1st place winners with free associate memberships to Texas Authors or to the Indie-Beacon organization. Through his non-profits, he has created new ways to market and sell books and galvanize authors into trying them to help fulfill their financial needs.

You can Learn more about Texas Authors, at their website TxAuthors.com -- Visiting the Members Only section of Texas Authors, Inc’s website you’ll find many articles, links and connections to a variety of items and people to help authors grow in marketing and selling books.

The award-winning Authors scheduled to attend this special PenCraft Award dinner and the “meet and greet” include:
Anne Howard, the author of the nonfictional book, "His Garden: Conversations with a Serial Killer." Howard's book will be featured in an episode of "21st Century Serial Killers," airing on Netflix in Europe in late 2018 and in America in 2019. Interviews with Howard were also featured in a recent episode of "Crime Watch Daily." Howard looks forward to answering your questions about her book and her upcoming NetFlix episode.

Brad Chisholm & Claire Kim from California, co-authors of "Kat & Maus" and "K-Town Confidential." are winners of multiple book awards. Their book, K-Town Confidential has that noir element that is centered around crime and featuring characters that are rendered powerless by situations rarely resolvable with a happy ending. The LA/K-Town setting is dark and mean and speaks to the difficult struggle of Korean immigrants assimilating to American culture. They will be present to answer questions about writing as a duo and questions about their two winning books.

Kishan Paul author of The Second Wife: The Second Wife Series (our book of the year) - A fast-paced psychologically stunning, intricately written piece of fiction that parallels the real-life dilemmas of the many women who are annually kidnapped in our world to be married off or to be used as sexual slaves. The National Crime Information Center (NCIC), reported that in 2010, the US had reported 355,243 women missing and unfortunately in 2018 the numbers will be worse.

Mark A. Hewitt, author of Airshow and Blown Cover - A first place winner in two categories. One of his books is a high-octane thriller with the protagonist, Duncan Hunter, a guy who makes the impossible possible. Hunter is one real cool customer even while he's also ‘the hunted’ by his enemies. Hunter isn’t simply some brawny guy with lots of guns, he's also educated and has proven himself as an adjunct college professor. Mark A. Hewitt is touring the U.S. and will be available at the "meet and greet." He will be honored at the PenCraft Award Dinner for his excellent literary contributions.

Chris Kelsey, author of Where the Hurt Is and our winner of best fiction book of the year will be flying in from New York to be a part of this event. Kelsey's book is a story about the murder of a young African-American woman whose naked, battered body is found by the railroad tracks in a small dusty all white west Oklahoma town. The story takes place in the spring of 1965 with racial tensions boiling over across the nation. Ex-Marine Emmett Hardy, the town’s police chief is thrust into solving the murder which most town folks just want to forget. Chief Emmett Hardy is not going to let that happen.

Isabella Murphy, the author of "From Dark to Light," wrote the book when she was a 5th grader. A couple of years later, Isabella’s book was published by Pink Umbrella Publishing. Her delightful book, beautifully illustrated by Natalia Perez, caught our eye and won 1st place for the PenCraft Award in the category of Children Books. Since the release of her book, Isabella has been an inspiration to other writers both young and old. Isabella who is from California and is now an 8th grader will be available to answer your questions about her life as an award-winning author.

Guillermo Marquez-Sterling the author of Praying for an Eclipse: Mother Moon (Volume 1) is a startling look at an oppressive World and life that most of us will never experience. He possesses a gift that enables him to paint a picture of fascinating characters and their surroundings, along with a credible dialogue that further illuminates the world he writes about; the cultural clashes, the characters torn between family obligations, societal forces, and passion. The novel is alive with memorable piercing images that are deeply disturbing yet true testaments of the life forced upon people viewed as society’s chaff. Guillermo a pastor, educator, and activist for sustainable change will be flying in from Florida to attend the Award Ceremony and answer questions about his book and the immigration quagmire.

Sharon K. Middleton the author of "Beyond McCarron's Corner: Sassy's Story," is based on historical events and set during the bittersweet years of our Revolution. The story is filled with the hope and faith that fortified our young nation in its Infancy. Middleton weaves her story around the famous Culper Spy Ring, organized in 1778, which ended up providing the kind of Information needed to defeat the British. The Culper Spy Ring became the most important spy rings organized by the Americans during the war and would supply General Washington with critical information that would help win the American Revolutionary War. Sharon K. Middleton will be available for the meet and greet and at the PenCraft Award dinner. She looks forward to meeting all attendees.

Philip Derrick is the author of “Facing the Dragon,” a Vietnam thriller about a young man’s struggle fighting not only the Vietcong but a killer among the troops that he will have to face. If you served in Vietnam, many of the locations and the descriptions of life as a grunt will ring true. Philip Derrick is a Vietnam veteran, so what he writes is quite authentic because he saw and lived it. Philip will be flying in from Seattle, Washington for the event. Veterans and their families are cordially invited to attend the event to help honor Philip Derrick, a brother in arms, scholar, and award-winning author.

Robert Shemeld won 1st Place in the category of Fiction - Thriller - Terrorist with his novel “The Narragansett Files.” It is a fast-paced spy and action thriller with a nautical twist. Shemeld wastes no time launching into his intriguing narrative. Within the first few pages of the novel, you discover the main character, Steele, is busy with the task of disposing of a body. What could have gone so terribly wrong on a sailing vacation with a couple, and their close friend? Well, piracy kidnapping and murder just might be at the top of the list. Shemeld is from Virgina.

The authors’ “meet and greet” is a new addition to the PenCraft Award ceremony. It offers a rare opportunity for fans, members of the press and authors to meet each other and enjoy all the award ceremony and dinner have to offer. The public is invited - For tickets goto PenCraftAward.com. Reported by PRWeb 47 minutes ago.

*Activities Underway to Support Planned Commercial Expansion**Management to Host Conference Call at 7:30 a.m. ET Today *

BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the three and nine months ended September 30, 2018, and provided an update on company operations.

Key Amarin achievements since its last quarterly report include:

· R&D progress: The Vascepa® (icosapent ethyl) cardiovascular outcomes study, REDUCE-IT™, reported topline results on September 24, 2018. REDUCE-IT met its primary endpoint demonstrating an approximately 25% relative risk reduction, to a high degree of statistical significance (p
“The landmark results of the REDUCE-IT study present an important opportunity to improve the practice of medicine with respect to preventative cardiovascular care. We believe that these outcomes study results position Vascepa to address a significant unmet medical need and could be considered the most significant breakthrough in preventative cardiovascular care since the advent of statin therapy decades ago.  We are very excited about the potential for Vascepa to help millions of patients and we are acting accordingly to expand on our established commercial foundation, including existing broad managed care coverage and extensive key opinion leader support,” stated John F. Thero, president and chief executive officer. “Amarin looks forward to the primary REDUCE-IT outcomes study results being presented at AHA and to working towards the future publication of these results in a major medical journal within 2018.”

*REDUCE-IT Cardiovascular Outcomes Study*

As previously announced, the REDUCE-IT outcomes study was designed to assess the putative cardiovascular effects of the prescription drug Vascepa at 4 grams/day in lowering the risk of cardiovascular events beyond LDL (“bad”) cholesterol management in patients with cardiovascular risk factors including elevated triglycerides. While the study enrolled patients with elevated triglyceride levels (≥135 mg/dL, median baseline 216 mg/dL), REDUCE-IT was a cardiovascular outcomes study and not a lipid-focused study.

Various prior therapies have sought to address the residual cardiovascular risk beyond bad cholesterol management and have failed, including CETP inhibitors, fibrates, nicotinic acid and omega-3 mixtures. Many of these therapies lower triglyceride levels but failed to demonstrate cardiovascular risk reduction in studied populations. The molecular structure and clinical effects and profile of Vascepa are unique. 

Data supporting the unique effects of Vascepa was accentuated during Q3 2018 when the report of the successful topline results of the REDUCE-IT cardiovascular outcomes study with Vascepa were announced shortly after cardiovascular outcomes study results were reported for prescription drug Lovaza® (named Omacor in Europe) from the ASCEND study. In the ASCEND study Lovaza at a low dose of 1 gram/day failed to demonstrate cardioprotective benefit. The REDUCE-IT topline results were also on the heels of a report in Q3 2018 by the independent Cochrane Foundation which reviewed available outcomes data for omega-3 products, including dietary supplements, showing that except for the successful study of a purified prescription EPA product in Japan (the JELIS study), omega-3 products have a consistent pattern of showing negligible cardioprotective effects. Note that omega-3 products containing DHA have been shown to increase bad cholesterol levels in relevant patient populations. 

Vascepa, as a single molecule active ingredient drug, does not contain DHA and has been shown in prior studies to not increase bad cholesterol in relevant patient populations. Patients in the REDUCE-IT study were enrolled with baseline median LDL cholesterol of 75 mg/dL controlled by statin therapy. In addition, omega-3 molecules are fragile and highly prone to oxidation (spoilage typically evidenced by a fishy smell) or other forms of degradation that can impact their effect and safety. Vascepa is manufactured through a stringent and complex FDA-regulated process designed to effectively eliminate impurities and isolate and protect the single molecule active ingredient against degradation.

Amarin is eager to share REDUCE-IT data in greater detail with both the medical community and regulatory authorities. As previously reported, REDUCE-IT results have been accepted for presentation at the 2018 Scientific Sessions of the American Heart Association (AHA) on November 10, 2018 in Chicago, Illinois. The presentation, classified as late breaking clinical trial results, is scheduled to commence at 2:18 pm Central Time and listed as Main Event 1 for the time frame.   

Until the AHA presentation, as agreed with AHA, Amarin does not plan to share any further details regarding the results of the REDUCE-IT study. Key topline results from the REDUCE-IT study as reported on September 24, 2018 include:

· Efficacy: Approximately 25% relative risk reduction, demonstrated to a high degree of statistical significance (p  
· Safety:  Vascepa was well tolerated with a safety profile consistent with clinical experience associated with omega-3 fatty acids and current FDA-approved labeling. The proportions of patients experiencing adverse events and serious adverse events in REDUCE-IT were similar between the active and placebo treatment groups. Median follow-up time in REDUCE-IT was 4.9 years.

*Commercial Update*

The REDUCE-IT cardiovascular outcomes study started in 2011.  Prior to knowing the results of this important study, Amarin devoted a majority of its resources to research and development.  The aggregate cost of supporting the REDUCE-IT clinical outcomes study plus more than 20 scientific publications and presentations per year is approximately $50 million or more annually.  As a result, resources available to support Vascepa marketing and sales have been limited. Over the past five years, Amarin has grown Vascepa revenues, based on an important but niche biomarker-based indication, with a professional, well-trained and productive sales team which for most of this period consisted of approximately 135 sales representatives. 

At the start of 2018, preparing for REDUCE-IT success, Amarin took select steps to prepare for anticipated commercial expansion following REDUCE-IT results.  These steps included modestly increasing the number of Vascepa sales representatives to 150 while continuing to maintain its commercial business (excluding R&D, financing and other costs described below) positive from a cash flow perspective; training leading sales representative to become managers; piloting consumer awareness initiatives; increasing levels of supply on hand while working with third-party suppliers to increase capacity; contracting with managed care for Vascepa insurance coverage well into 2019; soliciting resumes from experienced sales candidates; expanding relationships with key opinion leaders (KOLs), professional societies and patient advocacy groups; and making other selective preparations to strengthen Amarin’s foundation to support future commercial growth.

Following Amarin learning in late Q3 2018 that the results of the REDUCE-IT study were positive, Amarin expanded its sales management and began hiring additional sales representatives.  Nearly all of the new sales management positions the company sought to fill are now filled. The company is pleased to have ample experienced applicants to fill its open sales representative positions.  The company is on track to have a sales force of 400 sales representatives in the United States to start 2019.  New sales representatives are being hired with starting dates throughout Q4 and slotted for group training with the aim of having all new hires trained by year-end.  This broadened sales team will call on more than double the number of physicians targeted historically by Amarin’s sales team.  They will be supported in doing so by other promotional and market education programs.  Amarin believes that presentation and future publication of results from the REDUCE-IT study will be helpful as part of this education process with healthcare professionals.

Amarin plans to submit a supplemental new drug application (sNDA) in early 2019 seeking an expanded indication for Vascepa in the United States.

*Financial Update *

Net product revenue for the three months ended September 30, 2018 and 2017 was $55.0 million and $47.1 million, respectively. Net product revenue for the nine months ended September 30, 2018 and 2017 was $151.3 million and $126.3 million, respectively.  Increased revenue is mainly attributed to increased Vascepa prescriptions.  Amarin does not believe that these results were impacted by news of REDUCE-IT topline results or by steps taken to expand promotion of Vascepa after such results.

During the third quarter, based on data from Symphony Health Solutions and IQVIA, Amarin experienced continued prescription growth and an increase in Vascepa market share, particularly among detailed physicians. Symphony Health Solutions and IQVIA estimated normalized total Vascepa prescriptions of approximately 458,000 and 457,000, respectively, for the three months ended September 30, 2018, representing growth of approximately 19% and 22%, respectively, over levels estimated by these sources for the same three months of the prior year. 

Net pricing of Vascepa in the third quarter of 2018 was relatively consistent with the prior year and channel inventory levels remain in the ordinary range.

Licensing revenue during the three months ended September 30, 2018 and 2017 was $0.4 million and $0.3 million, respectively, related to timing of milestones and other factors impacting revenue recognition for licensing fees under agreements for the commercialization of Vascepa outside the United States.

Cost of goods sold during the nine months ended September 30, 2018 and 2017 was $37.0 million and $31.5 million, respectively. Gross margin on net product revenue for the nine months ended September 30, 2018 and 2017 were 76% and 75%, respectively.

Selling, general and administrative (SG&A) expense for the nine months ended September 30, 2018 and 2017 was $147.3 million and $98.9 million, respectively, an increase of $48.4 million, or 49%. This increase is due primarily to increased promotional activities, including commercial spend for anticipated expansion following successful REDUCE-IT results, including a pilot consumer promotion program, and increased co-promotion fees calculated on increased gross profit resulting from higher net product revenue, including an accrual of $10.7 million for co-promotion tail payments. The tail co-promotion fees, which are calculated as a percentage of the 2018 co-promotion fee, are payable in 2019 through 2021. Such co-promotion fee costs are currently scheduled to end on December 31, 2018. For the nine months ended September 30, 2018, the aggregate cost of the co-promotion fee, including the tail payment accrual, was $30.5 million.

Research and development (R&D) expense for the nine months ended September 30, 2018 and 2017 was $44.0 million and $35.2 million, respectively, an increase of $8.8 million, or 25%. This increase in expense is primarily driven by the timing of REDUCE-IT and related costs and the recording of $2.7 million in expense related to the company’s previously announced strategic collaboration with Mochida Pharmaceutical Co., Ltd.  We continue to anticipate that our level of spending on R&D will begin to decline following publication of results of the REDUCE-IT study; however, the company will continue to incur expenses related to seeking approval of an expanded indication for Vascepa based on submission of an sNDA as well as costs associated with the other R&D activities.    
                                                                                                       
Under U.S. GAAP, Amarin reported a net loss of $24.5 million in the three months ended September 30, 2018, or basic and diluted loss per share of $0.08. This net loss included $6.7 million in non-cash stock-based compensation expense. Amarin reported a net loss of $10.8 million in the third quarter of 2017, or basic and diluted loss per share of $0.04. This net loss included $3.5 million in non-cash stock-based compensation expense.

Under U.S. GAAP, Amarin reported a net loss of $82.8 million in the nine months ended September 30, 2018, or basic and diluted loss per share of $0.28. This net loss included $14.0 million in non-cash stock-based compensation expense. For the nine months ended September 30, 2017, Amarin reported a net loss of $45.4 million, or basic and diluted loss per share of $0.17. This net loss included $10.5 million in non-cash stock-based compensation expense.

Excluding non-cash gains or losses for stock-based compensation, non-GAAP adjusted net loss was $17.8 million for the third quarter of 2018, or non-GAAP adjusted basic and diluted loss per share of $0.06, compared to non-GAAP adjusted net loss of $7.3 million for the third quarter of 2017, or non-GAAP adjusted basic and diluted loss per share of $0.03.

Excluding non-cash gains or losses for stock-based compensation, non-GAAP adjusted net loss was $68.7 million for the nine months ended September 30, 2018, or non-GAAP adjusted basic and diluted loss per share of $0.24, compared to non-GAAP adjusted net loss of $34.9 million for the nine months ended September 30, 2017, or non-GAAP adjusted basic and diluted loss per share of $0.13.

Amarin reported cash and cash equivalents of $81.9 million as of September 30, 2018. Net cash flows for the nine months ended September 30, 2018, excluding the $70.0 million in net proceeds from the equity offering completed in the first quarter, was negative $61.8 million. Net cash flows for the same period was positive $20.9 million excluding cash flows associated with financing activities and REDUCE-IT.  More specifically, net cash flow was positive for this period excluding finance related proceeds and expenses (interest and royalty), excluding research and development payments (most of which relates to the REDUCE-IT study), excluding payments made in preparation for expansion upon positive REDUCE-IT results such as increasing Vascepa inventory levels, and excluding the one-time payment made related to the company’s previously announced agreement with Teva Pharmaceuticals USA, Inc.  

As of September 30, 2018, the company had $47.6 million in net accounts receivable ($62.7 million in gross accounts receivable before allowances and reserves), $25.7 million in other receivables due primarily from financial institutions resulting from the timing of stock option exercises in late September which amounts were collected in early October and $43.7 million in inventory.

As of September 30, 2018, Amarin had approximately 304.1 million American Depository Shares (ADSs) and ordinary shares outstanding, 28.9 million common share equivalents of Series A Convertible Preferred Shares outstanding and approximately 21.0 million equivalent shares underlying stock options at a weighted-average exercise price of $3.36, as well as 9.6 million equivalent shares underlying restricted or deferred stock units. On October 19, 2018, the company announced the forced exchange of its then outstanding $30.0 million in exchangeable notes.  Pursuant to such exchange, the company will issue approximately 7.7 million ADSs and eliminate its $30.0 million debt and related interest obligations.  Following this exchange, Amarin will have no outstanding debt. The company continues to have an obligation under a royalty-like arrangement which is paid off at a rate equal to 10% of net product revenue up to an aggregate payment of $94.1 million. There is no maturity date related to this royalty-like arrangement.

*Conference Call and Webcast Information*

Amarin will host a conference call at 7:30 a.m. ET today, November 1, 2018.  The call will be webcast live with slides and accessible through the investor relations section of the company’s website at www.amarincorp.com. The call can also be heard via telephone by dialing 877-407-8033. A replay of the call will be made available for a period of two weeks following the conference call. To hear a replay of the call, dial 877-481-4010 (inside the United States) or 919-882-2331 (outside the United States). A replay of the call will also be available through the company's website shortly after the call. For both dial-in numbers please use conference ID 38108.

*Use of Non-GAAP Adjusted Financial Information *

Included in this press release are non-GAAP adjusted financial information as defined by U.S. Securities and Exchange Commission Regulation G. The GAAP financial measure most directly comparable to each non-GAAP adjusted financial measure used or discussed, and a reconciliation of the differences between each non-GAAP adjusted financial measure and the comparable GAAP financial measure, is included in this press release after the condensed consolidated financial statements.

Non-GAAP adjusted net loss was derived by taking GAAP net loss and adjusting it for non-cash stock-based compensation expense. Management uses these non-GAAP adjusted financial measures for internal reporting and forecasting purposes, when publicly providing its business outlook, to evaluate the company’s performance and to evaluate and compensate the company’s executives. The company has provided these non-GAAP financial measures in addition to GAAP financial results because it believes that these non-GAAP adjusted financial measures provide investors with a better understanding of the company’s historical results from its core business operations.

While management believes that these non-GAAP adjusted financial measures provide useful supplemental information to investors regarding the underlying performance of the company’s business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the company’s results of operations as determined in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future.

*About Amarin*

Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing therapeutics to improve cardiovascular health. Amarin’s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa (icosapent ethyl) is Amarin's first FDA-approved drug and is available by prescription in the United States, Lebanon and the United Arab Emirates.  Amarin’s commercial partners are pursuing additional regulatory approvals for Vascepa in Canada, China and the Middle East. For more information about Amarin, visit www.amarincorp.com.

*About REDUCE-IT*

The REDUCE-IT cardiovascular outcomes study commenced in 2011, enrolled and followed 8,179 randomized patients, and was conducted based on a special protocol assessment agreement with FDA.

REDUCE-IT is the first global cardiovascular outcomes study to prospectively evaluate the effect of Vascepa, or any therapy, in adult patients with LDL-C controlled to between 41-100 mg/dL (median baseline 75 mg/dL) by statin therapy and various cardiovascular risk factors including persistent elevated TGs between 150-499 mg/dL (median baseline 216 mg/dL) and either established cardiovascular disease (secondary prevention cohort) or diabetes mellitus and at least one other CV risk factor (primary prevention cohort). The design of the REDUCE-IT cardiovascular outcomes study was published in March 2017 in Clinical Cardiology^1 and can be found in the R&D section on the company’s website at www.amarincorp.com. 

The REDUCE-IT hypothesis tested whether additional cardiovascular risk reduction beyond LDL-C controlled with statin therapy could be achieved in high risk patients with the putative cardioprotective effects of Vascepa 4 grams/day. Independent of REDUCE-IT, Amarin worked to support the REDUCE-IT hypothesis with published scientific findings based on various degrees of evidence that show EPA may interrupt the atherosclerotic process (e.g., plaque formation and instability) by beneficially affecting cellular functions thought to contribute to atherosclerosis and cardiovascular events and by beneficially affecting lipid, lipoprotein and inflammation biomarkers.^2, 3, 4, 5, 6 

*About VASCEPA^® (icosapent ethyl) Capsules*

Vascepa® (icosapent ethyl) capsules are a single-molecule prescription product consisting of the omega-3 acid commonly known as EPA in ethyl-ester form. Vascepa is not fish oil, but is derived from fish through a stringent and complex FDA-regulated manufacturing process designed to effectively eliminate impurities and isolate and protect the single molecule active ingredient from degradation. Vascepa, known in scientific literature as AMR101, has been designated a new chemical entity by the FDA.  Amarin has been issued multiple patents internationally based on the unique clinical profile of Vascepa, including the drug’s ability to lower triglyceride levels in relevant patient populations without raising LDL-cholesterol levels.

Indication and Usage Based on Current FDA-Approved Label (not including REDUCE-IT results)

· Vascepa (icosapent ethyl) is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia.
· The effect of Vascepa on the risk for pancreatitis and cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined.

Important Safety Information for Vascepa Based on Current FDA-Approved Label (not including REDUCE-IT results) (Includes Data from Two 12-Week Studies (n=622) (MARINE and ANCHOR) of Patients with Triglycerides Values of 200 to 2000 mg/dL)

· Vascepa is contraindicated in patients with known hypersensitivity (e.g., anaphylactic reaction) to Vascepa or any of its components.
· In patients with hepatic impairment, monitor ALT and AST levels periodically during therapy.
· Use with caution in patients with known hypersensitivity to fish and/or shellfish.
· The most common reported adverse reaction (incidence >2% and greater than placebo) was arthralgia (2.3% for Vascepa, 1.0% for placebo). There was no reported adverse reaction >3% and greater than placebo.
· Adverse events and product complaints may be reported by calling 1-855-VASCEPA or the FDA at 1-800-FDA-1088.
· Patients receiving treatment with Vascepa and other drugs affecting coagulation (e.g., anti-platelet agents) should be monitored periodically.
· Patients should be advised to swallow Vascepa capsules whole; not to break open, crush, dissolve, or chew Vascepa.

FULL VASCEPA PRESCRIBING INFORMATION CAN BE FOUND AT WWW.VASCEPA.COM.

Vascepa has been approved for use by the United States Food and Drug Administration (FDA) as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Nothing in this press release should be construed as promoting the use of Vascepa in any indication that has not been approved by the FDA.

*About Cardiovascular Disease *

Worldwide, cardiovascular disease (CVD) remains the #1 killer of men and women. In the United States CVD leads to one in every three deaths – one death approximately every 38 seconds – with annual treatment cost in excess of $500 billion.^7, 8

Beyond the cardiovascular risk associated with LDL-C, genetic, epidemiologic, clinical and real-world data suggest that patients with elevated triglycerides (TG) (fats in the blood), and TG-rich lipoproteins, are at increased risk for cardiovascular disease.^  9, 10, 11, 12

*Forward-Looking Statements  *

This press release contains forward-looking statements, including expectations regarding planned scientific presentation, publication, regulatory review and related timing thereof, including plans to submit an sNDA in early 2019 seeking an expanded indication for Vascepa in the United States; and expected costs relating to the foregoing; statements regarding Vascepa’s ability to address a significant unmet medical need and potentially being the most significant breakthrough in preventative cardiovascular care since the advent of statin therapy; expectations that REDUCE-IT results could lead to a new treatment paradigm in the patient population studied; plans for sales force, international and insurance coverage expansion as well as sales force training and deployment. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. In addition, Amarin's ability to effectively commercialize Vascepa will depend in part on its ability to continue to effectively finance its business, efforts of third parties, its ability to create market demand for Vascepa through education, marketing and sales activities, its ability to obtain an expanded indication for Vascepa in the United States, to achieve market acceptance of Vascepa, to receive adequate levels of reimbursement from third-party payers, to develop and maintain a consistent source of commercial supply at a competitive price, to comply with legal and regulatory requirements in connection with the sale and promotion of Vascepa and to maintain patent protection for Vascepa. Among the factors that could cause actual results to differ materially from those described or projected herein include the following: uncertainties associated generally with research and development, clinical trials and related regulatory approvals; the risk that sales may not meet expectations and related cost may increase beyond expectations; the risk that patents may not be upheld in patent litigation and applications may not result in issued patents sufficient to protect the Vascepa franchise. A further list and description of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin's filings with the U.S. Securities and Exchange Commission, including its most recent quarterly report on Form 10-Q. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Amarin undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

*Availability of Other Information About Amarin*

Investors and others should note that Amarin communicates with its investors and the public using the company website http://www.amarincorp.com/), the investor relations website (http://investor.amarincorp.com/), including but not limited to investor presentations and investor FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts.  The information that Amarin posts on these channels and websites could be deemed to be material information.  As a result, Amarin encourages investors, the media, and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis.  This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels.  The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

*References*

^1 Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif J-C, Ketchum SB, Doyle RT Jr, Murphy SA, Soni PN, Braeckman RA, Juliano RA, Ballantyne CM and on behalf of the REDUCE-IT Investigators. Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial.* *Clin Cardiol. 2017;40:138-148.
^2 Ganda OP, Bhatt DL, Mason RP, et al. Unmet need for adjunctive dyslipidemia therapy in hypertriglyceridemia management. J Am Coll Cardiol. 2018;72(3):330-343.
^3 Borow KM, Nelson JR, Mason RP. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis. 2015;242(1):357-366.
^4 Nelson JR, Wani O, May HT, et al. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques. Vascul Pharmacol. 2017;91:1–9.
^5 Mason RP, Dawoud H, Jacob RF, et al. Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin. Biomed Pharmacother. 2018;103:1231-1237.
^6 Takamura M, Kurokawa K, Ootsuji H, et al. Long-term administration of eicosapentaenoic acid improves post-myocardial infarction cardiac remodeling in mice by regulating macrophage polarization. J Am Heart Assoc. 2017;6(2). pii: e004560. 
^7 American Heart Association. 2018. Disease and Stroke Statistics-2018 Update.
^8 American Heart Association. 2017. Cardiovascular disease: A costly burden for America projections through 2035.
^9 Budoff M. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease. Am J Cardiol. 2016;118:138-145.
^10 Toth PP, Granowitz C, Hull M, et al. High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real-world analysis of statin-treated patients with high cardiovascular risk and well-controlled low-density lipoprotein cholesterol [abstract]. Circulation. 2017;136(suppl 1):A15187.
^11 Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease - New insights from epidemiology, genetics, and biology. Circ Res. 2016;118:547-563.
^12 Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014; 384: 626–635.

*Amarin Contact Information*

Investor Relations:
Elisabeth Schwartz
Investor Relations and Corporate Communications
Amarin Corporation plc
In U.S.: +1 (908) 719-1315
investor.relations@amarincorp.com

Lee M. Stern
Trout Group 
In U.S.: +1 (646) 378-2992
lstern@troutgroup.com

Media Inquiries:
Christy Maginn
Burson-Marsteller
In U.S.: +1 (646) 280-5210
Christy.Maginn@bm.com

*CONSOLIDATED BALANCE SHEET DATA*
*(U.S. GAAP)*
*Unaudited*
         
    *September 30, 2018*   *December 31, 2017*
     
    *(in thousands)*
*ASSETS*        
Current Assets:        
Cash and cash equivalents   $ 81,892     $ 73,637  
Restricted cash     600       600  
Accounts receivable, net     47,648       45,318  
Other receivables     25,654       —  
Inventory, net     43,673       30,260  
Prepaid and other current assets     2,935       3,455  
Total current assets     202,402       153,270  
Property, plant and equipment, net     69       28  
Other long-term assets     174       174  
Intangible asset, net     7,642       8,126  
*TOTAL ASSETS*   $ 210,287     $ 161,598  
*LIABILITIES AND STOCKHOLDERS’ DEFICIT*        
Current Liabilities:        
Accounts payable   $ 26,174     $ 25,155  
Accrued expenses and other current liabilities     93,899       58,902  
Current portion of exchangeable senior notes, net of discount     219       481  
Current portion of long-term debt from royalty-bearing instrument     30,130       22,348  
Deferred revenue, current     1,220       1,644  
Total current liabilities     151,642       108,530  
Long-Term Liabilities:        
Exchangeable senior notes, net of discount     29,159       28,992  
Long-term debt from royalty-bearing instrument     53,924       70,834  
Deferred revenue, long-term     19,736       17,192  
Other long-term liabilities     8,652       1,150  
Total liabilities     263,113       226,698  
Stockholders’ Deficit:        
Preferred stock     21,850       24,364  
Common stock     232,646       208,768  
Additional paid-in capital     1,057,408       977,866  
Treasury stock     (9,867 )     (4,229 )
Accumulated deficit     (1,354,863 )     (1,271,869 )
Total stockholders’ deficit     (52,826 )     (65,100 )
*TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT*   $ 210,287     $ 161,598  
         

 

*CONSOLIDATED STATEMENTS OF OPERATIONS DATA*
*(U.S. GAAP)*
*Unaudited*
                       
  *Three months ended September 30,*   *Nine months ended September 30,*
  *(in thousands, except per share amounts)*   *(in thousands, except per share amounts)*
  *2018*   * * *2017*     *2018*   * * *2017*  
Product revenue, net $ 54,973     $ 47,051     $ 151,286     $ 126,343  
Licensing revenue   350       309       598       895  
Total revenue, net   55,323       47,360       151,884       127,238  
Less: Cost of goods sold   13,541       11,921       37,035       31,520  
Gross margin   41,782       35,439       114,849       95,718  
Operating expenses:                      
Selling, general and administrative (1)   49,960       33,194       147,310       98,910  
Research and development (1)   14,072       10,694       43,993       35,211  
Total operating expenses   64,032       43,888       191,303       134,121  
Operating loss   (22,250 )     (8,449 )     (76,454 )     (38,403 )
Interest expense, net   (2,163 )     (2,401 )     (6,188 )     (7,097 )
Other (expense) income, net   (58 )     25       (134 )     100  
Loss from operations before taxes   (24,471 )     (10,825 )     (82,776 )     (45,400 )
(Provision for) benefit from income taxes   —       —       —       —  
Net loss $ (24,471 )   $ (10,825 )   $ (82,776 )   $ (45,400 )
Loss per share:                      
Basic $ (0.08 )   $ (0.04 )   $ (0.28 )   $ (0.17 )
Diluted $ (0.08 )   $ (0.04 )   $ (0.28 )   $ (0.17 )
Weighted average shares:                      
Basic   295,595       270,803       291,526       270,566  
Diluted   295,595       270,803       291,526       270,566  
                       
(1) Excluding non-cash stock-based compensation, selling, general and administrative expenses were $44,357 and $30,223 for the three months ended September 30, 2018 and 2017, respectively, and research and development expenses were $13,024 and $10,170, respectively, for the same periods. Excluding non-cash stock-based compensation as well as co-promotion fees paid to the company's U.S. co-promotion partner, selling, general and administrative expenses were $33,200 and $24,295 for the three months ended September 30, 2018 and 2017, respectively.
 

 
*RECONCILIATION OF NON-GAAP NET LOSS*
*Unaudited*
                 
    *Three months ended September 30,**
*   *Nine months ended September 30,*
    *(in thousands, except per share amounts)**
*   *(in thousands, except per share amounts)*
    *2018**
* * * *2017**
*   *2018* * * *2017*
Net loss for EPS^1 - GAAP   $   (24,471 )   $   (10,825 )   $   (82,776 )   $   (45,400 )
Non-cash stock-based compensation expense       6,651         3,495         14,032         10,471  
Adjusted net loss for EPS^1 - non-GAAP   $   (17,820 )   $   (7,330 )   $   (68,744 )   $   (34,929 )
                 
^1basic and diluted                
                 
Loss per share:                
Basic and diluted - non-GAAP   $   (0.06 )   $   (0.03 )   $   (0.24 )   $   (0.13 )
                 
Weighted average shares:                
Basic and diluted       295,595         270,803         291,526         270,566  
                  Reported by GlobeNewswire 41 minutes ago.

HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported net loss of $6.4 million, ($0.22 diluted loss per share) for the three months ended September 30, 2018. These results compare to net loss of $5.0 million, ($0.18 diluted loss per share) for the same period a year ago.“Despite customer scheduling and weather delays during the third quarter, we remain bullish on the long-term outlook of the Company due to our solid bid market and second highest backlog in Company’s history,” said Mark Stauffer, Orion Group Holding's President and Chief Executive Officer.  “Our Marine segment continues to see strong demand and we continue to have solid project execution.  As previously noted, during the third quarter, we experienced delays in new project awards as well as customer permitting delays.  Additionally, our Concrete segment experienced project delays due to continuous rain patterns throughout Texas in August and September.    Given the quick cycle nature of our business, we encourage investors to focus on long term results, as we do, rather than quarter to quarter fluctuations.”

*Consolidated Results for Third Quarter 2018 compared to Third Quarter 2017*

· Contract revenues were $125.1 million, a decrease of 10.8% as compared to revenues of $140.2 million.  The decrease is primarily attributed to the timing and mix of projects and weather patterns in Texas.· Gross profit was $5.9 million, as compared to gross profit of $10.8 million. Gross profit margin was 4.7% as compared to 7.7%.  This decrease is primarily attributed the timing and mix of projects and weather patterns in Texas.· Selling, General and Administrative expenses were $14.4 million as compared to $16.5 million.  The decrease is driven by cost saving initiatives and decreased legal fees.· Operating loss was $7.4 million as compared to an operating loss of $5.4 million.· EBITDA was $0.7 million, representing a 0.5% EBITDA margin as compared to EBITDA of $2.0 million, or 1.4% EBITDA margin.

*Segment Results for Third Quarter 2018 Compared to Third Quarter 2017*

*Marine Segment*

· Contract revenues were $63.5 million, a decrease of 7.2% as compared to $68.4 million.  The decrease is primarily attributed to the timing and mix of projects driven by customer schedules.· Operating loss was $5.6 million, as compared to an operating loss of $9.8 million.  The increase is attributed to the three Hurricanes that impacted roughly eighty percent of Marine operations in the third quarter of last year.· EBITDA was $2.5 million, representing a 4.0% EBITDA margin as compared to $(2.4) million EBITDA and a (3.5)% EBITDA margin.

*Concrete Segment*

· Contract revenues were $61.6 million, a decrease of 14.2%, as compared to $71.8 million.  The decrease is primarily attributed to delays caused by continuous rain patterns throughout the Texas market during August and September.· Operating loss was $1.8 million, as compared to operating income of $4.5 million. The decrease is primarily attributed to delays caused by continuous rain patterns throughout Texas during August and September.· EBITDA was $(1.9) million, representing a (3.0)% EBITDA margin as compared to $4.4 million EBITDA and an 6.1% EBITDA margin.

*Backlog*Backlog of work under contract as of September 30, 2018 was the Company's second highest backlog in its history at $426 million and an increase of 11.2% compared with backlog under contract at September 30, 2017 of $383 million.  Of the September 30, 2018 backlog, $238.1 million was attributable to the Marine segment, while $187.9 million was attributable to the Concrete segment. The increase in backlog is due to the timing and mix of project awards and continues to support the Company's positive outlook.  Currently, the Company has $1.1 billion worth of bids outstanding, including approximately $63 million on which it is the apparent low bidder, or have been awarded subsequent to the end of the third quarter, of which approximately $58 million pertains to the Marine segment and approximately $5 million to the Concrete segment.

"During the third quarter, we bid on approximately $871 million and were successful on approximately $210 million," said Chris DeAlmeida, Orion Group Holding's Executive Vice President and Chief Financial Officer.  "This resulted in a 1.68 times book-to-bill ratio and a win rate of 24.1%.  In the Marine segment, we bid on approximately $341 million during the third quarter 2018 and were successful on $117 million, which translated into a 1.84 times book-to-bill ratio and a win rate of 34.3%.  The Concrete segment bid on approximately $530 million in work while being awarded approximately $93 million.  This yielded a 1.52 times book-to-bill ratio and a win rate of 17.5%."

Backlog consists of projects under contract that have either (a) not been started, or (b) are in progress and not yet complete, and the Company cannot guarantee that the revenue projected in its backlog will be realized, or if realized, will result in earnings.  Backlog can fluctuate from period to period due to the timing and execution of contracts.  Given the typical duration of the Company's projects, which generally range from three to nine months, the Company's backlog at any point in time usually represents only a portion of the revenue it expects to realize during a twelve-month period.

*Business Sector Overviews*

The Infrastructure sector, which consists of the Marine segment, provides both public and private opportunities to maintain and expand marine facilities on and over U.S. waterways.  Market fundamentals in this segment continue to provide promising opportunities for future jobs.  Specifically, expansion of private sector waterside facilities continues, with solid demand from private recreational customers, including bid opportunities for cruise industry infrastructure, as well as continued solid demand from the downstream energy sector.

The Building sector, which consists of the Concrete segment, continues to see solid demand as its three major metropolitan markets retain their positions as leading centers for population growth and business expansion.  Population growth is driving new distribution centers, office expansion, retail and grocery establishments, multi-family housing units, educational facilities and medical facilities.  In Houston, the Company continues to experience competitive pressure in the market but expects to maintain market share.  The Company continues to focus on expanding its market share in the Dallas-Fort Worth market, including adding structural opportunities.  Also, solid growth opportunities are expected in the Central Texas market, as the Company continues to see fundamentally strong end market drivers.

In the Industrial sector, the Company continues its greenfield expansion by combining talent and resources from the Marine segment and Concrete segment to execute and pursue foundation and other work inside the industrial environment.  The Company is currently executing industrial projects with several additional bids and bid opportunities developing.  The Company continues to expect the massive long-term petrochemical driven opportunities along the Gulf Coast to provide significant project opportunities with outpaced growth in the petrochemical industry.

*Outlook*

“During the first six months of 2018, we experienced solid project execution, continued strong demand, and favorable working conditions,” stated Mr. Stauffer.  “While we experienced some delays that adversely effected our results in the third quarter and may impact the fourth quarter, these are related to the timing of awards, weather, and the natural quick cycle nature of our business. Year to date, we have had improved performance with top line and bottom line growth and we remain optimistic about the long-term outlook for our business.  We continue to remain focused on cost controls as well as reducing underutilized assets.  Our strategic plan is working, we are headed in the right direction, we remain focused on increasing shareholder value and we continue to believe the Company has a strong outlook, with solid prospects for continued bottom line growth in the future. Currently, we have $1.1 billion worth of total bids outstanding.  However, given the impacts from the third quarter, we will not meet our EBITDA outlook for 2018 as previously anticipated.  Currently, we believe our full year 2018 EBITDA outlook will be in the range of the  high twenties to low thirties."

*Conference Call Details*

Orion Group Holdings will host a conference call to discuss results for the third quarter 2018 at 10:00 a.m. Eastern Time/9:00 a.m. Central Time on Thursday, November 1, 2018. To listen to a live webcast of the conference call, or access the replay, visit the Calendar of Events page of the Investor Relations section of the website at www.oriongroupholdingsinc.com.  To participate in the call, please dial the Orion Group Holdings, Inc. Third Quarter 2018 Earnings Conference Call toll free at (855) 478-9690; participant code: 8889892.

*About Orion Group Holdings*

Orion Group Holdings, Inc., a leading specialty construction company, provides services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment.  The Company’s marine segment services include marine transportation, facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services.  Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas.  The Company is headquartered in Houston, Texas with regional offices throughout its operating areas.

*Non-GAAP Financial Measures*

This press release includes the financial measures “adjusted net income,” “adjusted earnings per share,” “EBITDA,” and “EBITDA margin."  These measurements are “non-GAAP financial measures” under rules of the Securities and Exchange Commission, including Regulation G.  The non-GAAP financial information may be determined or calculated differently by other companies. By reporting such non-GAAP financial information, the Company does not intend to give such information greater prominence than comparable and other GAAP financial information, which information is of equal or greater importance.

Adjusted net income and adjusted earnings per share should not be considered as an alternative to net income available to common stockholders or earnings per share.  Adjusted net income and adjusted earnings per share exclude certain items that management believes affect the comparability of operating results. The company believes these adjusted financial measures are a useful adjunct to earnings calculated in accordance with GAAP because management uses adjusted net income available to common stockholders to evaluate the company's operational trends and performance relative to other companies. Items excluded, generally are one-time items or items whose timing or amount cannot be reasonably estimated.  Accordingly, any guidance provided by the company generally excludes information regarding these types of items.

Orion Group Holdings defines EBITDA as net income before net interest expense, income taxes, depreciation and amortization.  EBITDA margin is calculated by dividing EBITDA for the period by contract revenues for the period.  The GAAP financial measure that is most directly comparable to EBITDA is net income, while the GAAP financial measure that is most directly comparable to EBITDA margin is operating margin, which represents operating income divided by contract revenues.  EBITDA and EBITDA margin are used internally to evaluate current operating expense, operating efficiency, and operating profitability on a variable cost basis, by excluding the depreciation and amortization expenses, primarily related to capital expenditures and acquisitions, and net interest and tax expenses.  Additionally, EBITDA and EBITDA margin provide useful information regarding the Company's ability to meet future debt repayment requirements and working capital requirements while providing an overall evaluation of the Company's financial condition.  In addition, EBITDA is used internally for incentive compensation purposes.  The Company includes EBITDA and EBITDA margin to provide transparency to investors as they are commonly used by investors and others in assessing performance.  EBITDA and EBITDA margin have certain limitations as analytical tools and should not be used as a substitute for operating margin, net income, cash flows, or other data prepared in accordance with generally accepted accounting principles in the United States, or as a measure of the Company's profitability or liquidity.

*Forward-Looking Statements*

The matters discussed in this press release may constitute or include projections or other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of which the Company is availing itself.  Certain forward-looking statements can be identified by the use of forward-looking terminology, such as 'believes', 'expects', 'may', 'will', 'could', 'should', 'seeks', 'approximately', 'intends', 'plans', 'estimates', or 'anticipates', or the negative thereof or other comparable terminology, or by discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals.  In particular, statements regarding future operations or results, including those set forth in this press release (including those under “Outlook” above), and any other statement, express or implied, concerning future operating results or the future generation of or ability to generate revenues, income, net income, profit, EBITDA, EBITDA margin, or cash flow, including to service debt, and including any estimates, forecasts or assumptions regarding future revenues or revenue growth, are forward-looking statements.  Forward looking statements also include estimated project start date, anticipated revenues, and contract options which may or may not be awarded in the future.  Forward looking statements involve risks, including those associated with the Company's fixed price contracts that impacts profits, unforeseen productivity delays that may alter the final profitability of the contract, cancellation of the contract by the customer for unforeseen reasons, delays or decreases in funding by the customer, levels and predictability of government funding or other governmental budgetary constraints and any potential contract options which may or may not be awarded in the future, and are the sole discretion of award by the customer.  Past performance is not necessarily an indicator of future results.  In light of these and other uncertainties, the inclusion of forward-looking statements in this press release should not be regarded as a representation by the Company that the Company's plans, estimates, forecasts, goals, intentions, or objectives will be achieved or realized.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company assumes no obligation to update information contained in this press release whether as a result of new developments or otherwise.

Please refer to the Company's Annual Report on Form 10-K, filed on March 13, 2018, which is available on its website at www.oriongroupholdingsinc.com or at the SEC's website at www.sec.gov, for additional and more detailed discussion of risk factors that could cause actual results to differ materially from our current expectations, estimates or forecasts.

*Contact*
Orion Group Holdings Inc.
Shane Martin, Investor Relations (972) 850-2001

*Orion Group Holdings, Inc. and Subsidiaries*
*Consolidated Statements of Operations*
*(In Thousands, Except Share and Per Share Information)*
*(Unaudited)*

  *Three months ended September 30,* *Nine months ended September 30,*
  *2018* *2017* *2018* *2017*
Contract revenues $ 125,073   $ 140,162   $ 421,682   $ 416,339  
Costs of contract revenues 119,135   129,405   379,154   377,200  
Gross profit 5,938   10,757   42,528   39,139  
Selling, general and administrative expenses 14,371   16,524   46,249   49,031  
(Gain) loss on sale of assets, net (1,028 ) (413 ) (2,527 ) (590 )
Other gain from continuing operations —   —   (5,448 ) —  
Operating income (loss) from operations (7,405 ) (5,354 ) 4,254   (9,302 )
Other (expense) income        
Other income 1,143   9   1,617   30  
Interest income 52   11   100   11  
Interest expense (3,217 ) (1,369 ) (5,899 ) (4,186 )
Other expense, net (2,022 ) (1,349 ) (4,182 ) (4,145 )
(Loss) income before income taxes (9,427 ) (6,703 ) 72   (13,447 )
Income tax (benefit) expense (3,071 ) (1,666 ) 78   (4,309 )
Net loss (6,356 ) (5,037 ) (6 ) (9,138 )
         
Basic loss per share $ (0.22 ) $ (0.18 ) $ —   $ (0.33 )
Diluted loss per share $ (0.22 ) $ (0.18 ) $ —   $ (0.33 )
Shares used to compute loss per share:        
Basic 28,490,530   27,950,829   28,421,850   27,980,074  
Diluted 28,490,530   27,950,829   28,421,850   27,980,074  
                 

*Orion Group Holdings, Inc. and Subsidiaries*
*Selected Results of Operations*
*(In Thousands, Except Share and Per Share Information)*
*(Unaudited)*

  *Three months ended September 30,* *Nine months ended September 30,*
  *2018* *2017* *2018* *2017*
*Marine*        
  Contract revenues $ 63,479   $ 68,383   $ 206,967   $ 197,566  
  Operating (loss) income (5,559 ) (9,837 ) 4,348   (26,160 )
         
*Concrete*        
  Contract revenues $ 61,594   $ 71,779   $ 214,715   $ 218,773  
  Operating (loss) income (1,846 ) 4,483   (94 ) 16,858  
                 

*Orion Group Holdings, Inc. and Subsidiaries*
*EBITDA and EBITDA Margin Reconciliations*
*(In Thousands, Except Margin Data)*
*(Unaudited)*

  *Three months ended September 30,* *Nine months ended September 30,*
  *2018* *2017* *2018* *2017*
         
Operating (loss) income $ (7,405 ) $ (5,354 ) $ 4,254   $ (9,302 )
Other (expense) income 1,143   9   1,617   30  
Depreciation and amortization expense 6,922   7,304   21,134   22,422  
EBITDA^(1) $ 660   $ 1,959   $ 27,005   $ 13,150  
Operating (loss) income margin^(2) (5.0 )% (3.8 )% 1.4 % (2.3 )%
Impact of depreciation and amortization 5.5 % 5.2 % 5.0 % 5.4 %
EBITDA margin^(1) 0.5 % 1.4 % 6.4 % 3.1 %

^(1) EBITDA is a non-GAAP measure that represents earnings before interest, taxes, depreciation and amortization. EBITDA margin is a non-GAAP measure calculated by dividing EBITDA by contract revenues.
^(2) Operating margin is calculated by dividing operating income (loss), plus other income, by contract revenues.

*Orion Group Holdings, Inc. and Subsidiaries*
*EBITDA and EBITDA Margin Reconciliations by Segment*
*(In Thousands, Except Margin Data)*
*(Unaudited)*

  *Marine*
  *Three months ended September 30,* *Nine months ended September 30,*
  *2018* *2017* *2018* *2017*
         
Operating income (loss) $ (5,559 ) $ (9,837 ) $ 4,348   $ (26,160 )
Other income 3,323   2,371   8,903   6,519  
Depreciation and amortization expense 4,746   5,075   14,772   15,417  
EBITDA^(1) $ 2,510   $ (2,391 ) $ 28,023   $ (4,224 )
Operating (loss) income margin^(2) (3.5 )% (10.9 )% 6.4 % (9.9 )%
Impact of depreciation and amortization 7.5 % 7.4 % 7.1 % 7.8 %
EBITDA margin^(1) 4.0 % (3.5 )% 13.5 % (2.1 )%

  *Concrete*
  *Three months ended September 30,* *Nine months ended September 30,*
  *2018* *2017* *2018* *2017*
         
Operating income (loss) $ (1,846 ) $ 4,483   $ (94 ) $ 16,858  
Other expense (2,180 ) (2,362 ) (7,286 ) (6,489 )
Depreciation and amortization expense 2,176   2,229   6,362   7,005  
EBITDA^(1) $ (1,850 ) $ 4,350   $ (1,018 ) $ 17,374  
Operating (loss) income margin^(2) (6.5 )% 3.0 % (3.4 )% 4.7 %
Impact of depreciation and amortization 3.5 % 3.1 % 3.0 % 3.2 %
EBITDA margin^(1) (3.0 )% 6.1 % (0.4 )% 7.9 %

^(1) EBITDA is a non-GAAP measure that represents earnings before interest, taxes, depreciation and amortization. EBITDA margin is a non-GAAP measure calculated by dividing EBITDA by contract revenues.
^(2) Operating margin is calculated by dividing operating income (loss), plus other income, by contract revenues.

*Orion Group Holdings, Inc. and Subsidiaries*
*Consolidated Balance Sheets*
*(In Thousands, Except Share and Per Share Information)*

  *September 30,
 2018* *December 31,
 2017*
  *(Unaudited)* *(Audited)*
*ASSETS*    
Current assets:    
Cash and cash equivalents $ 2,594   $ 9,086  
Accounts receivable:    
Trade, net of allowance of $0 and $0, respectively 81,181   84,953  
Retainage 30,216   39,189  
Other current 5,415   3,706  
Income taxes receivable 395   339  
Inventory 3,757   4,386  
Costs and estimated earnings in excess of billings on uncompleted contracts 57,411   46,006  
Prepaid expenses and other 2,939   4,124  
Total current assets 183,908   191,789  
Property and equipment, net 144,387   146,278  
Inventory, non-current 4,781   4,915  
Goodwill 69,483   69,483  
Intangible assets, net of amortization 15,634   18,175  
Other non-current 6,555   $ 2,645  
Total assets $ 424,748   $ 433,285  
*LIABILITIES AND STOCKHOLDERS’ EQUITY*    
Current liabilities:    
Current debt, net of debt issuance costs $ 40,650   $ 22,756  
Accounts payable:    
Trade 31,360   45,194  
Retainage 1,717   1,990  
Accrued liabilities 17,699   17,873  
Taxes payable —   256  
Billings in excess of costs and estimated earnings on uncompleted contracts 24,528   33,923  
Total current liabilities 115,954   121,992  
Long-term debt, net of debt issuance costs 55,770   63,185  
Other long-term liabilities 4,460   3,573  
Deferred income taxes 12,682   13,243  
Interest rate swap liability —   26  
Total liabilities 188,866   202,019  
Stockholders’ equity:    
Preferred stock -- $0.01 par value, 10,000,000 authorized, none issued —   —  
Common stock -- $0.01 par value, 50,000,000 authorized, 29,677,843 and 28,860,961 issued; 28,966,619 and 28,149,737 outstanding at September 30, 2018 and December 31, 2017, respectively 296   288  
Treasury stock, 711,231 shares, at cost, as of June 30, 2018 and December 31, 2017, respectively (6,540 ) (6,540 )
Other comprehensive income (loss) 357   (26 )
Additional paid-in capital 179,214   174,697  
Retained earnings 62,555   62,847  
Total stockholders’ equity 235,882   231,266  
Total liabilities and stockholders’ equity $ 424,748   $ 433,285  

*Orion Group Holdings, Inc. and Subsidiaries*
*Consolidated Statements of Cash Flows*
*(In Thousands)*
*(Unaudited)*

  *Nine months ended September 30,*
  *2018* *2017*
Cash flows from operating activities:    
Net income (loss) $ (6 ) $ (9,138 )
Adjustments to reconcile net income (loss) to net cash provided by (used in):    
Operating activities:    
Depreciation and amortization 21,134   22,422  
Unamortized debt issuance costs on debt extinguishment 2,164   —  
Deferred financing cost amortization 676   942  
Deferred income taxes (561 ) (5,478 )
Stock-based compensation 1,710   1,800  
Gain on sale of property and equipment (2,527 ) (590 )
Other gain from continuing operations (5,448 ) —  
Change in operating assets and liabilities:    
Accounts receivable 11,036   19,930  
Income tax receivable (56 ) (2,203 )
Inventory 763   74  
Prepaid expenses and other 3,410   1,481  
Costs and estimated earnings in excess of billings on uncompleted contracts (11,405 ) (6,859 )
Accounts payable (14,266 ) 2,225  
Accrued liabilities (1,925 ) (836 )
Income tax payable (256 ) 2,364  
Billings in excess of costs and estimated earnings on uncompleted contracts (9,395 ) 5,721  
Other (287 ) —  
Net cash (used in) provided by operating activities (5,239 ) 31,855  
Cash flows from investing activities:    
Proceeds from sale of property and equipment 2,320   6,361  
Contributions to CSV life insurance (424 ) (430 )
Acquisition of TBC —   (6,000 )
TBC acquisition adjustment —   (557 )
Insurance claim proceeds related to property and equipment 1,346   —  
Purchase of property and equipment (15,043 ) (7,234 )
Proceeds from return of investment 94   —  
Net cash used in investing activities (11,707 ) (7,860 )
Cash flows from financing activities:    
Borrowings from Credit Facility 29,861   52,000  
Payments made on borrowings from Credit Facility (21,361 ) (74,438 )
Exercise of stock options 2,815   1,007  
Loan costs from Credit Facility (861 ) (210 )
Net cash provided by (used in) financing activities 10,454   (21,641 )
Net change in cash and cash equivalents (6,492 ) 2,354  
Cash and cash equivalents at beginning of period 9,086   305  
Cash and cash equivalents at end of period $ 2,594   $ 2,659  
Supplemental disclosures of cash flow information:    
Cash paid during the period for:    
Interest $ 2,994   $ 3,232  
Taxes, net of refunds $ 472   $ 1,067   Reported by GlobeNewswire 41 minutes ago.

Pittsburgh, PA, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Hyde Marine, a division of Calgon Carbon Corporation, announced today that it successfully completed its land-based testing for the Hyde GUARDIAN® ballast water treatment system (BWTS) that covers both USCG Type Approval requirements and Revised IMO G8 Guidelines.  The testing protocol requires a minimum of 15 successful test runs in three different water salinities under varying and extremely challenging water conditions.

The Hyde GUARDIAN® BWTS utilizes filtration with medium-pressure UV for disinfection.  The system originally received IMO Type Approval in 2009, and USCG Alternate Management System acceptance in 2013.  Completion of this new round of land-based testing in accordance with the USCG preferred stain test method is a key step in the application process for USCG Type Approval, as well as qualifying the system under the Revised IMO G8 Guidelines.  The phases of the USCG Type Approval process include documentation review, bench testing, land-based testing, shipboard testing, and environmental testing.

“Completion of land-based testing is a great milestone for our team and for our product,” says Chris Todd, Executive Director of Hyde Marine.  “We are still in the process of shipboard testing for the Hyde GUARDIAN® system, and we expect to be able to submit our USCG Type Approval application in the summer of 2019 following its completion.  We are eager to help ship owners comply with both USCG and IMO ballast water management regulations.”

*About Calgon Carbon Corporation*

Calgon Carbon, a wholly-owned subsidiary of Kuraray Co., Ltd. (TYO: 3405) (Kuraray), is a global leader in the manufacture and/or distribution of innovative coal-, wood- and coconut-based activated carbon products – in granular, powdered, pelletized and cloth form – to meet the most challenging purification demands of customers throughout the world.

Complemented by world-class activated carbon and ultraviolet (UV) light purification and disinfection equipment systems and service capabilities, as well as diatomaceous earth and perlites, Calgon Carbon provides purification solutions for more than 700 distinct applications, including drinking water, wastewater, pollution abatement, and a variety of industrial and commercial manufacturing processes.

Headquartered in Pittsburgh, Pennsylvania, Calgon Carbon employs approximately 1,300 people and operates 20 manufacturing, reactivation, innovation and equipment fabrication facilities in the U.S., Asia, and in Europe, where Calgon Carbon is known as Chemviron.

Calgon Carbon was acquired by Kuraray in March of 2018. With complementary products and services, the combined organization will continue to focus on providing the highest quality and most innovative activated carbon and filtration media products, equipment, and services to meet customer needs anywhere in the world. For more information, visit calgoncarbon.com.

About Hyde Marine

Hyde Marine is part of Calgon Carbon UV Technologies LLC.  With more than 100 years in the maritime industry and pioneering development of ballast water treatment technologies, Hyde Marine has become the leading U.S. manufacturer and educator regarding regulations, technologies, installation experiences, and challenges facing this sector. Since its initial launch in 1998, the Hyde GUARDIAN® BWTS has emerged as an industry leader featuring mechanical separation with filtration followed by UV disinfection – with more than 500 Hyde GUARDIAN® units sold to date for installation in various ship types and sizes around the world.

###CONTACT: Amanda Lofty
Calgon Carbon Corporation
724-541-2658
alofty@calgoncarbon.com Reported by GlobeNewswire 21 hours ago.

TAMPA, Fla., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, announced today that it has entered into agreements with a small group of  institutional investors, led by large long-term holders of OMEX,  to receive $5.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants consisting of 700,000 shares of the company’s common stock and 700,000 5-year immediately exercisable warrants to purchase 700,000 shares of common stock at an exercise price of $7.155 per share. If the warrants are exercised for cash in full, the company would receive additional gross proceeds of approximately $5.0 million.“This funding, when combined with the expected future revenue from contracted projects and profit participation from the current recovery project under contract, is expected to fund Odyssey into 2020, based on our current budgets,” stated Mark Gordon, President and CEO of Odyssey Marine Exploration. “The proceeds from this offering also give us flexibility to take advantage of new strategic opportunities that have the potential to deliver significant value in the near future and allow us to accelerate early stage production development or other expenses for our Mexican phosphate project.

The offering is expected to close on or about November 2, 2018, subject to the satisfaction of customary closing conditions. The net proceeds of the financing will be used for general corporate purposes, including working capital.

Chardan acted as the lead placement agent for this transaction.

The securities described above are being offered by Odyssey Marine Exploration through a prospectus supplement pursuant to Odyssey’s shelf registration statement on Form S-3 as previously filed and declared effective by the Securities and Exchange Commission and the base prospectus contained therein (Registration No. 333-227666). A prospectus supplement related to the offering will be filed with the Securities and Exchange Commission (SEC). This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The securities are being be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. Copies of the final prospectus supplement and accompanying base prospectus may be obtained, when available, by contacting Chardan Capital Markets, LLC, 150 East 58th Street, 28th Floor, New York, NY 10155, at (646) 465-9028, or the Securities and Exchange Commission's website at http://www.sec.gov.

*About Odyssey Marine Exploration*
Odyssey Marine Exploration, Inc. (Nasdaq:OMEX) is engaged in deep-ocean exploration using innovative methods and state-of-the-art technology to provide access to critical resources worldwide. Our core focus is the discovery, development and extraction of deep-ocean minerals. Odyssey also provides marine services for private clients and governments. For additional details, please visit www.odysseymarine.com. 

*Forward Looking Information*
Odyssey Marine Exploration believes the information set forth in this Press Release may include "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the Securities and Exchange Commission on March 26, 2018. The financial and operating projections as well as estimates of mining assets are based solely on the assumptions developed by Odyssey that it believes are reasonable based upon information available to Odyssey as of the date of this release. All projections and estimates are subject to material uncertainties and should not be viewed as a prediction or an assurance of actual future performance. The validity and accuracy of Odyssey's projections will depend upon unpredictable future events, many of which are beyond Odyssey's control and, accordingly, no assurance can be given that Odyssey's assumptions will prove true or that its projected results will be achieved.

*Cautionary Note to U.S. Investors*
The U.S. Securities and Exchange Commission (SEC) permits mining companies, in their filings with the SEC, to disclose only those mineral deposits that a company can economically and legally extract or produce. We use certain terms in this press release, such as "measured", "indicated,""inferred" and "resources," which the SEC guidelines strictly prohibit us from including in our filings with the SEC. "Inferred mineral resources" have a great amount of uncertainty as to their existence, and great uncertainty as to their economic and legal feasibility. It cannot be assumed that all or any part of an inferred mineral resource will ever be upgraded to a higher category. U.S. investors are cautioned not to assume that part or all of the inferred mineral resource exists, or is economically or legally mineable, and are urged to consider closely the disclosures in our Form 10-K which may be secured from us or from the SEC's website at http://www.sec.gov/edgar.shtml.

CONTACT: CONTACT:
Laura Barton
Odyssey Marine Exploration, Inc.
(813) 876-1776 x 2562
laura@odysseymarine.com  Reported by GlobeNewswire 21 hours ago.

CHICAGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Lincoln Property Company swept the 2018 Chicagoland Apartment Marketing and Management Excellence (CAMME) Awards last week, taking home nine trophies.The Chicagoland Apartment Association (CAA), in conjunction with the Chicago Tribune, hosted the 25^th annual awards ceremony on Friday, October 26. CAMME awards are presented in recognition of superior contributions and exemplary achievements in the multifamily housing industry.

· COMMUNITY AMENITIES PACKAGE (Mid-Rise/Hi-Rise), Niche 905
· MAINTENANCE TEAM (Mid-Rise/Hi-Rise), Cityfront Place
· RESIDENT RELATIONS & RETENTION INITIATIVE OR PROGRAM, west77 Apartments
· SOCIAL MEDIA PROGRAM (Corporate), Lincoln Property Company - #LPCstaycation
· INDIVIDUAL MARKETING/ADVERTISING PIECE (Corporate), Lincoln Property Company - LPC Look Book
· LEASING PROFESSIONAL (Mid-Rise/Hi-Rise), Ali O’Hara - Tides & Shoreham at Lakeshore East
· CHIEF ENGINEER/MAINTENANCE SUPERVISOR (Mid-Rise/Hi-Rise), Faton Neziri - Cityfront Place
· PROPERTY EXCELLENCE Built Between 1967 - 1994 (Mid-Rise/Hi-Rise), Cityfront Place
· PROPERTY EXCELLENCE Built Between 1995 - 2011 (Mid-Rise/Hi-Rise), 180 North Jefferson

“I can’t tell you how proud I am of the Lincoln Chicago team!  We are fortunate to have an incredibly dedicated group of professionals who commit themselves every day to excellence in all that they do,” says Bruce Webster, Senior Vice President for Lincoln Property Company in the Midwest Region.

*About Lincoln Property Company*

Lincoln Property Company was founded in 1965 as a builder and operator of high-quality residential communities. In the early 1970's, Lincoln expanded its product mix to include commercial, build-to-suit, office, hotel, industrial, and other mixed-use assets. In 1972, Lincoln took this expertise within the United States to Western Europe and the Middle East.

In 2001, Lincoln joined forces with the U.S. Department of Defense to renovate and redevelop family housing at selected bases for the Navy, the Marine Corps, and the Army. Through innovative management, property rehabilitation and award-winning new construction designs, Lincoln is now one of the largest operators of military housing in the country.

Headquartered in Dallas, TX, Lincoln focuses on real estate investment, construction and development, in addition to property management. Their national reputation has enabled Lincoln to attract a large client base of owners and investors who count on their ability to deliver quality results and continually serve as a market leader.

For more information about Lincoln Property Company, please visit www.lincolnapts.com/about/client-services or www.lincolnapts.com/communities for apartment listings in your area.

Media Contact:

Sheri Sandefur Killingsworth, Vice President - Marketing & Communications
214-740-3300 | corporate@lpsi.com
SOURCE Lincoln Property Company Reported by GlobeNewswire 21 hours ago.

· *The 2018 BMW M5 is the latest V8-powered beast to emerge from the horsepower addicts of Bavaria.*
· *I spent a week putting the BMW M5 through its savage paces — and it scared me. A lot!*
· *The M5 is a mighty monster of a machine that provides a four-door alternative to some supercars.*Let's face it, people like to hate on BMW. 

This is depressing because for decades, the Bavarian motoring giant has proven again and again that the whole "ultimate driving machine" thing was utterly, totally, completely legit. BMWs are unquestionably among the most thrilling cars a human can drive and have been for ages. 

Blame the yuppified 1980s, when BMWs became status-mobiles. Then throw in some aggressive leasing deals that meant every new Hollywood agent or junior law partner could slip into a 3-Series.

Thankfully, BMW's M Sport performance division doesn't care about young agents or tyro lawyers and continues to focus on taking cars such as the 2018 5-Series, a perfectly brilliant luxury sedan, and turning them into terrifying beast-machines designed to alter the movement of entire planets.

You think that's an overstatement. OK, fine, but you didn't just spend a week driving around in a 2018 BMW M5.

What is this car like? Remember that scene in "Avengers: Infinity War" when Thor arrived in Wakanda via bifrost express and slung his hefty new hammer, Stormbreaker, to devastating effect? BOOM! 

The M5 is about 1,000 times more exciting than that. And you can have the same one I did in your driveway for $130,000. 

Yep, that ain't cheap. But considered in terms of a cost-to-motoring-nirvana ratio, it's a magnificent bargain. Plus, you don't have to unleash hell with the M5 every time you start it up. The car can be dialed back to relative calm — calm enough, sort of, for daily commuting. True, you'll be buying a lot of premium fuel; the M5 gets 15 mpg city/21 highway/17 combined, adding a $1,000 gas-guzzler tax to the sticker price. But pleasure such as this car delivers cannot be entirely quantified.

Let me go into greater detail about why the 2018 M5 is basically the baddest four-door in our realm:

*SEE ALSO: The best Buick money can buy is a $44,000 rebuke to European sport sedans — here's what it's like to drive*

*FOLLOW US: On Facebook for more car and transportation content!*

-The 2018 M5! Our test car came in a Marine Bay Blue Metallic paint job and benefitted from a $4,000 Executive Package, including rear sunshades, wireless-device charging, and a WiFi hotspot.--We checked out the un-M'd 5-Series last year. The 5-Series in now in its seventh generation.-

*Read the review »*-BMW's M cars always up the burliness factor, design-wise. The normal 5-Series looks stately and executive, while the M5 looks bold and aggressive.-
See the rest of the story at Business Insider Reported by Business Insider 20 hours ago.

After 28 years of service, Retired Marine Sergeant Major Marty Kenny found his new Mission and Purpose by creating The Weekly Fight. The Weekly Fight is a registered 501c3 non-profit company whose mission is: “To forge a bond between Veterans and the community to maximize their civilian potential.”

PHILADELPHIA (PRWEB) November 01, 2018

After 28 years of service, Retired Marine Sergeant Major Marty Kenny found his new Mission and Purpose by creating The Weekly Fight. The Weekly Fight is a registered 501c3 non-profit company whose mission is: “To forge a bond between Veterans and the community to maximize their civilian potential.”

The Weekly Fight was founded when one of SgtMaj. Kenny’s Marines committed suicide after an invisible battle with PTSD. Two years after The Weekly Fight’s inception, the mission to forge a bond between Veterans and the community to maximize their civilian potential, SgtMaj’s vision of turning Post-Traumatic Stress into Post-Traumatic Growth has come to life.

Stars and Stripes cited in June 2018 of this year, "The VA has now revealed the average daily number of veteran suicides has always included deaths of active-duty service members and members of the National Guard and Reserve, not just veterans." As our nation continues to face these deep wounds of war, the 20 that commit suicide per day is The Weekly Fight's daily battle to combat the visible and invisible wounds of war.

Kenny stated..."I have now lost more Marines to suicide than from combat. I believed something needed to be done for our veteran community. We don’t talk about suicide before it happens and we don’t provide solutions to this problem. My biggest push is trying to get our veterans out of post-traumatic stress disorder mindset. When we come together at The Weekly Fight, we are regaining that sense of camaraderie ... it opens these veterans up to begin sharing and talking, it brings them together, and it brings the veterans families together. As The Weekly Fight opens up its fifth chapter in the northeast region of the country, this Veterans Day, we lead the fight for our veterans to overcome the violent struggle and have post-traumatic growth."

The Weekly Fight currently hosts weekly workouts free to Veterans, first responders, and their family members in Pennsylvania, Delaware and Northern Virginia. The Weekly Fight is now serving our nation's veterans in five locations including Frazer, Oxford, Lancaster, Manayunk, and Wilmington Delaware. The Weekly Fight is adding least two additional locations before the end of 2018.

ABOUT: Marty Kenny, SGTMAJ (RET)

Sergeant Major Martin Kenny graduated from Parris Island in May 1986 as the Series High Shooter. Upon graduation from boot camp, Private Kenny was assigned to Marine Air Group 49 in Willow Grove, Pennsylvania as a combat engineer. Sergeant Kenny joined Bulk Fuel Company C in Folsom, Pennsylvania in 1995 as Platoon Guide. Shortly after joining this command Sergeant Kenny was assigned a Platoon as a Platoon Sergeant.

In January 1998 he was selected for Staff Sergeant and assumed collateral duties as Company Career Planner. Later that same year, Bulk Fuel Company C was converted to a Bridging Company in order to better serve the Marine Logistics Group. Staff Sergeant Kenny attended the SNCO Academy in 1998 at Camp Crowder Michigan. Staff Sergeant Kenny mobilized in October of 2002 with Bridge Company Bravo as a Platoon Sergeant in support of Operation Iraqi Freedom. While serving in Iraq Staff Sergeant Kenny was responsible for destroying more than 75,000 lbs of enemy ordnance was well as completing several bridging missions across the Tigris River. The company demobilized in July 2003.

In January 2004 Staff Sergeant Kenny was mobilized in support of Operation Iraqi Freedom II. During this time the Company was attached to the 420th Army Engineer Brigade. Staff Sergeant Kenny conducted more than 20 bridging operations as well serving as Convoy Commander on numerous convoys logging more than 16,000 miles. On 1 July 2004 Staff Sergeant Kenny was selected for the rank of Gunnery Sergeant and promoted at Camp Anaconda Iraq. Gunnery Sergeant Kenny was demobilized in September 2004. From September 2004 until May 2009 Gunnery Sergeant Kenny served in many capacities at Bridge Company including Platoon Commander, Operations Chief and First Sergeant.

In July 2004 Gunnery Sergeant attended the Advance SNCO Academy in Quantico Virginia. From September 2004 until May 2009 Gunnery Sergeant Kenny served in many capacities at Bridge Company including Platoon Commander, Operations Chief and First Sergeant. In July 2004 Gunnery Sergeant attended the Advance SNCO Academy in Quantico Virginia. Gunnery Sergeant Kenny was mobilized in May 2009 in support of Operation Iraqi Freedom 9.2.

On 1 May 2009, Gunnery Sergeant Kenny was selected for the rank of First Sergeant. He was assigned to Combat Logistics Battalion 46 as the First Sergeant of Engineer Company. Engineer Company was responsible for the route clearance and the retrograding of equipment and vehicles to facilitate the withdrawal of Marines from Iraq.

In January 2010 First Sergeant Kenny was selected to train a Battalion for the 215 Corps Afghan National Army. First Sergeant Kenny deployed to Afghanistan and worked with the Afghan National Army until the end of March 2010. First Sergeant Kenny was demobilized in May of 2010. In April of 2013 First Sergeant Kenny was promoted to the rank of Sergeant Major and assigned to HMH772, MAG49.

In July of 2015 Sergeant Major Kenny retired from the Marine Corps after thirty years of service. Sergeant Major Kenny’s awards and decorations include Meritorious Service Medal, Navy and Marine Corps Achievement Medal, Army Commendation Medal, Combat Action Ribbon. Reported by PRWeb 20 hours ago.

PEMBROKE, Bermuda, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sompo International Holdings Ltd., a Bermuda-based specialty provider of property and casualty insurance and reinsurance, announced today that the company has entered into a strategic partnership with CropTrak™, a leading provider of technology solutions for the food and agriculture markets. CropTrak’s enterprise software platform enables growers, enterprise food and agri-business companies on a global basis to measure and increase the sustainability, traceability and regulatory compliance of crop production. Real-time monitoring, reporting and predictive analytics help CropTrak clients improve farm and food production practices. The new exclusive global partnership between Sompo International and CropTrak will provide advanced insurance and risk management solutions to growers, insurance agents and agri-businesses.This global partnership is an expansion of a strategic relationship that began in 2016 in the U.S. between CropTrak and ARMtech Insurance Services, a wholly-owned subsidiary of Sompo International and the sixth-largest underwriter of U.S. federally sponsored crop insurance. ARMtech’s cutting-edge crop insurance software, AgriNet, integrates with CropTrak to provide clients and agents an accurate and efficient mechanism for insurance data collection and acreage and production reporting under the trade name AgKeeper™.

AgKeeper uses advanced mobile and web-based software to improve the accuracy and efficiency of data collection, management and reporting across the agriculture and food supply chain. The software combines in-field data entry with integration into smart sensors with Internet of Things (IoT) capabilities to support agronomy, food safety, regulatory compliance and sustainability initiatives. Sustainability and productivity are becoming quite critical to agriculture profitability in key markets around the world where AgriSompo, Sompo International’s global platform, delivers innovative insurance and reinsurance solutions for agribusinesses.

Mr. Brian Goshen, Chief Administrative Officer, Sompo International, will join the CropTrak Board of Directors. Mr. Goshen commented, “We look forward to partnering with CropTrak as we continue to enhance our crop insurance capabilities and expand our presence in the U.S. through ARMtech and the global markets we serve through AgriSompo. By leveraging cutting edge technology solutions, we will deliver enriched insurance products, solutions, and customer experiences across a wide range of agribusinesses globally.”

Mr. Michael Smith, CEO of ARMtech added, “Expanding our existing relationship with CropTrak enables us to provide our agriculture clients with AgKeeper’s best-in-class technology to support product traceability and sustainability. ARMtech’s reputation is built on extensive agribusiness experience and exceptional customer support, so AgKeeper’s capabilities will expand the crop insurance solutions and productivity-enhancing tools we offer to our farmers and agents.”

Mr. Aaron Hutchinson, President and Cofounder of CropTrak, remarked. “We are pleased to expand our existing relationship with ARMtech into a strategic partnership with Sompo International. We look forward to combining our leading-edge technology solutions with their expertise in crop insurance and risk management to enhance the global suite of products that we offer our premier food and agriculture clients.”

*About Sompo International *

Sompo International Holdings Ltd. is a global specialty provider of property and casualty insurance and reinsurance, headquartered in Bermuda. Through its operating subsidiaries, Sompo International writes agriculture, professional lines, property, marine, energy, casualty and other specialty lines of insurance and catastrophe, property, casualty, professional lines, weather risk and specialty lines of reinsurance. Sompo International companies are wholly owned subsidiaries of Sompo Holdings, Inc., whose core business encompasses one of the largest property and casualty insurance groups in the Japanese domestic market. We maintain excellent financial strength as evidenced by the ratings of A+ (Superior) from A.M. Best (XV size category) and A+ (Strong) from Standard and Poor’s on our principal operating subsidiaries. Sompo International’s headquarters are located at Waterloo House, 100 Pitts Bay Road, Pembroke HM 08, Bermuda and its mailing address is Sompo International, Suite No. 784, No. 48 Par-la-Ville Road, Hamilton HM 11, Bermuda. For more information about Sompo International, please visit www.sompo-intl.com.

*About ARMtech Insurance Services*

ARMtech, an operating subsidiary of Sompo International, is a leading provider of federally sponsored Multi-Peril Crop Insurance and other private crop insurance products throughout the United States. A recognized leader in technology, ARMtech is focused on providing superior insurance products and services through a wide network of independent insurance agents. ARMtech’s headquarters are located at 7101 82nd Street Lubbock, TX 79424. To learn more, visit www.ARMT.com or call ARMtech at (800) 335-0120.

*About CropTrak *

CropTrak is dedicated to helping feed the world with safe and traceable food by deploying a flexible enterprise software platform that tracks the production of food using advanced mobile and web-based technologies. Its highly customizable software solution improves customer accuracy, efficiency and timeliness in data collection, management and reporting on a global scale. CropTrak is deployed in 15 languages in over 50 countries to enterprise food and agriculture clients. CropTrak’s global headquarters are located at 6303 E. Tanque Verde Road, Tucson, AZ 85715. For more information, visit www.icroptrak.com.

*Contact*
Investor Relations
Phone: +1 441 278 0988
Email: investorrelations@sompo-intl.com

  Reported by GlobeNewswire 20 hours ago.

In a new article published in Phycologia, researchers detail the collection, examination and classification of the foreign marine algae from the Japanese tsunami of 2011 to determine whether it posed an invasive threat to the North American coastline. Their findings provide insight into the global impact of tsunamis.

LAWRENCE, Kan. (PRWEB) November 01, 2018

Phycologia – In March 2011, the Great Tohoku Earthquake and Tsunami devastated the Pacific Coast of Japan; however, the tsunami also had global implications. When the water from the 40-m waves that pounded the coastline finally receded, a lot of debris from the island was carried out to sea. This debris, ranging from beach docks to boats to small flotation devices, started washing up on the shores of the Pacific Northwest in the United States in 2012, bringing with it fouling foreign marine algae that posed a major invasive threat to the US coastline.
In the current issue of Phycologia, researchers from Oregon State University, United States, and Kobe University, Japan, detail the collection, examination and classification of these foreign marine algae from their first appearance in 2012 through 2016 when the debris appeared to have subsided. The main goal of the research was to assess the algae and determine whether it posed an invasive threat to the North American coastline.

As the debris settled on beaches, the researchers, with the enlisted help of state workers, volunteers and other scientists, worked to collect samples of the attached algae. Overall, more than 500 samples were collected from 42 pieces of debris. Once collected and delivered, the samples were immediately examined and cataloged. Each sample was meticulously evaluated for the following characteristics: taxonomy, life history (including longevity and successional type), global distribution, size, how many times it appeared on different debris, at-sea survival and Northeast Pacific occurrence both pre- and post-tsunami.

The researchers identified 84 species and varieties of algae and cyanobacteria from the debris. They noted that 83% were reproductive, 48% were ephemeral and 75% were opportunistic. This led them to conclude that many species had high colonization potential upon reaching the shores of the Pacific Northwest. They also found that 72% of the species were globally widespread. Not all species survived the more than 4-year study. The short-term survivors appeared to be the larger species, whereas the long-term survivors were the smaller species, and tended to be the species with the highest invasive potential.

The researchers’ findings indicate that if not dealt with immediately, the risk of colonization was extremely high from the foreign debris. Dr. Gayle Hansen, a researcher in this study, stated, “Many of the items were fouled with a wide variety of healthy Japanese species and the potential invasion of Northeast Pacific shores by these species seemed highly probable. From 2012 to 2016, we studied the algae arriving on debris and discovered 84 species, ranging from large kelp to small filamentous forms. A surprisingly large number of these species were reproductive (83%), a feature that increased both their survival on debris and also their colonization risk. Realizing the invasion threat, the government agencies and volunteers in these two states immediately began removing the fouled debris from the beaches. With a subsidy from the Japanese Ministry of the Environment, the cleanup efforts were remarkably extensive. This alone appears to have prevented many invasions, and even today, no new algal colonizations have been found that can be directly linked to tsunami debris.”

The researchers concluded that due to the swift cleanup efforts, no foreign species was able to colonize upon reaching US shores. However, this study proves the global impacts of a tsunami. Once debris is swept out to sea, the foreign species of marine algae that are attached have a high probability of colonization when they finally wash ashore, if not handled immediately.
Full text of the article, “Invasion threat of benthic marine algae arriving on Japanese tsunami marine debris in Oregon and Washington, USA,” Phycologia, Vol. 57, No. 6, 2018, is available at http://www.phycologia.org/doi/full/10.2216/18-58.1 Reported by PRWeb 19 hours ago.

KEMP, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Larson Electronics, a Texas-based company with over 40 years leading the industrial lighting and equipment sector, announced the release of an explosion proof control station that provides protection for electrically operated devices in Class I, Division 1 and Class II, Division 2 locations. This control station is rain tight and includes a 30mA trip rating, external push-to-test buttons and two, 20-amp CFI breakers.The EPCS-2XGFCI.20A.30MA-2XPL-120V is a durable explosion proof ground fault control station that is designed for flammable work sites. This single-pole 20-amp control station features a 30mA trip rating and includes two sets of operating shafts that enable on/off and trip selections. Two 20-amp GFI breakers and push-to-test buttons are also included, as well as incandescent pilot lights to allow operators to monitor the system’s status.

The explosion proof ground fault control station is engineered for reliability and longevity, constructed of copper-free cast aluminum with stainless steel and Type 6 nylon hardware. This NEMA-rated unit is suitable for wet locations and features two, 1.25" NPT conduit hubs with a feed-through configuration. Back-located mounting feet allow this device to be wall or surface mounted.

“This control station provides electrical safety for equipment operating in combustible environments, chemical processing and other hazardous locations,” said Rob Bresnahan, CEO of Larson Electronics LLC. “This unit is rain tight, making it suitable for wet locations.”

*About Larson Electronics LLC: *Larson Electronics LLC is a manufacturer of industrial lighting equipment and accessories. The company offers an extensive catalog of industry-grade lighting and power distribution products for the following sectors: manufacturing, construction, food processing, oil and gas, military, marine and automobile. Customers can benefit from the company’s hands-on, customized approach to lighting solutions. Larson Electronics provides expedited service for quotes, customer support and shipments.

*For further information, please contact:*
Rob Bresnahan, *President and CEO
*Toll-free: 1-800-369-6671
Phone: 214-616-6180
Fax: 903-498-3364
E-mail: sales@larsonelectronics.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b11c0e91-6701-418b-9c33-a053f3f7e185 Reported by GlobeNewswire 19 hours ago.

Magaya is proud to join the effort to keep our oceans and waterways clean of plastic waste by switching to reusable cutlery and cups for all employees.

MIAMI (PRWEB) November 01, 2018

Magaya is proud to join the effort to keep our oceans and waterways clean of plastic waste by switching to reusable cutlery and cups for all employees.

"To reduce the number of plastic water bottles that end up in the trash, we replaced the bottles that we kept in our conference room refrigerators with refillable pitchers and beautiful cups that we wash instead of throw away," said Gabriel Ruz, Magaya Co-founder and CEO of Revenue.

"We also stopped buying Styrofoam cups. We used to buy four boxes a month of 1,000 cups each. That's 48,000 cups per year. Multiply that across all the companies in Miami, and imagine the number of single-use, disposable cups in our community. We’re just one company, but when we realized that yearly number, we felt compelled to make a change. We cut the waste by giving every employee their own Contigo water bottle. We also purchase kits of steel forks, knives spoons and chopsticks for each employee. We got a variety of colors for employees to choose from, and they love them."

Plastics from consumable items such as beverage bottles and caps, food wrappers, straws and bags account for millions of pieces of trash collected from waters. See the infographic on the "As You Sow" website for more numbers:
https://www.asyousow.org/our-work/waste/ocean-plastics

The supply chain industry is in great position to make an impact on improving the environment, for example, by reducing paper documentation with the eAWB, reducing carbon emissions from cargo ships, responsible ballast water policies, safe transport of live animals, fair pay and working conditions for ship employees, and more in many areas of the supply chain.

We applaud the recent announcement by Mondelez International that they will make all their packaging recyclable by 2025. Mondelez produces beverages, candy, crackers, cookies and other snacks. Other large corporations making similar commitments include Unilever and Kraft Heinz. Unilever products include soaps, cleansers, tea, ice cream and more. Kraft Heinz makes ketchup, cheese, beans, coffee and more. That's a lot of plastic bottles, cardboard boxes, and plastic wrappers. Each company's website includes details about their efforts to make a positive impact on communities and the environment.

"As far as back 2015 a study estimated that 8 million tons of plastics are swept into waterways annually — equivalent to a garbage truckload every minute. In the marine environment, plastics break down into indigestible particles that marine life mistake for food. If no actions are taken, oceans are expected to contain more plastic than fish by 2050." (source: Material Handling & Logistics. October 11, 2018):

https://www.mhlnews.com/global-supply-chain/mondelez-joins-pg-colgate-palmolive-make-packaging-recyclable

“We glad to make a contribution, both as part of our community and the world,” Mr. Ruz said.

About Magaya Corporation

We develop software that automates and improves business operations. Our customers include leaders in the fields of logistics, warehousing, wholesaling and nearly every aspect of the supply chain. Our philosophy is to simplify complex and redundant processes to reduce or eliminate inefficiency. The growth of our customers is our growth, so we dedicate ourselves to help them succeed.

In addition to continuously improving our software offering, we provide a complete range of consulting and implementation services to help your business accomplish your goals. The ripple effect of us creating the best products, providing the best customer training and support is we fulfill our promise to always be ahead. We help you innovate, automate and be more efficient. Reported by PRWeb 19 hours ago.

Dublin, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The "Commercial Seaweeds Market by Type (Red Seaweeds, Brown Seaweeds, Green Seaweeds), Method of Harvesting (Aquaculture, Wild Harvesting), Form (Liquid, Powder, Flakes), Application (Food, Feed, Agriculture), and Region - Global Forecast to 2023" report has been added to *ResearchAndMarkets.com's* offering.The commercial seaweeds market is estimated at USD 14.08 billion in 2018. It is projected to reach USD 21.11 billion by 2023, at a CAGR of 8.4%.The market is driven by its functional properties, which widens the new growth prospects for the food processing industry and the application of seaweeds and seaweed extracts, such as agar, carrageen, and alginate, which are used as gelling, binding, and thickening agents in the food, textile, and other manufacturing industries.

The growth of the brown seaweed segment, in terms of value, is estimated to dominate the global commercial seaweeds market in 2018. Brown seaweeds are increasingly used in the production of high-grade alginates. The increasing use of alginates in dental products is encouraging the leading companies to manufacture alginates from brown seaweeds. In the agriculture sector, brown seaweed extracts are used to produce organic fertilizers due to its potassium-rich content. The growing use of brown seaweeds in the manufacture of bio-plastics is further projected to fuel the market growth.

However, excessive use of seaweed products can adversely affect consumer's health due to the presence of toxic minerals such as heavy metal residues. This has led to increasing health concerns, globally, which, in turn, serves as a restraining factor for the growth of the commercial seaweeds market.

*The red seaweed is estimated to dominate the global commercial seaweeds market, in terms of volume.*

Red seaweeds are the largest group of seaweeds that are directly consumed as food due to their high content of essential nutrients, such as vitamins, minerals, and antioxidants. As the red seaweeds are nutrition-dense, they are largely used in various food products, such as soups, salads, snacks, and sushi. Red seaweeds are preferred more due to their nutrition and protein-rich properties in comparison to brown and green seaweeds. These seaweeds are also used to manufacture agar and carrageenan, which are widely used as a thickening and gelling agents. On account of these factors, the red seaweed is projected to witness high demand in the global market.

*Seaweeds harvested from aquaculture is projected to witness the fastest growth in the commercial seaweeds market from 2018 to 2023.*

Seaweeds are mainly obtained from aquaculture and are used for extraction and production of carrageenan and alginates. The rise in demand for aquaculture seaweeds as a raw material for the hydrocolloid industry to manufacture carrageenan, agar-agar, and alginates is projected to reflect positively on the overall market growth. Furthermore, the cultivation of aquaculture seaweeds does not require large setups and causes minimum harm to fishery resources and seabed. In the developing countries, this method acts as a sustainable activity, which also provides an alternative livelihood for the small-scale fishing community. Due to these factors, seaweed aquaculture remains high across regions, contributing toward the overall market growth.

*North America is projected to be the fastest-growing market for commercial seaweeds from 2018 to 2023.*

North American is projected to be the fastest-growing market for commercial seaweeds during the forecast period. The demand for commercial seaweeds in North America is driven by various factors such as increasing industrial applications of seaweeds and the growing awareness about its functional properties for enhancing the nutritive value in food as well as feed additives. The use of seaweeds in medical applications is also gaining traction in North America due to its high protein, calcium, antioxidants, iodine, potassium, iron, folic acid, fiber, omega-3, low-fat, and sodium content.*Key Topics Covered:**1 Introduction*
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.4 Periodization Considered
1.5 Currency Considered
1.6 Volume Unit Considered
1.7 Stakeholders

*2 Research Methodology*
2.1 Research Data
2.2 Market Size Estimation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Limitations

*3 Executive Summary*

*4 Premium Insights*
4.1 Attractive Opportunities in the Commercial Seaweeds Market
4.2 Commercial Seaweeds Market, By Key Country
4.3 Asia Pacific: Commercial Seaweeds Market, By Application & Key Country
4.4 Commercial Seaweeds Market, By Type & Region
4.5 Commercial Seaweeds Market, By Form & Region
4.6 Commercial Seaweeds Market, By Method of Harvesting

*5 Market Overview*
5.1 Introduction
5.2 Commercial Seaweeds Market Dynamics
5.2.1 Drivers
5.2.1.1 Functional Properties of Edible Seaweeds Open Up New Prospect for the Food Processing Industry
5.2.1.2 Increase in Seaweed Harvesting to Cater to the Growing Demand for Seaweeds & Seaweed-Based Products
5.2.1.3 Seaweed Farming - An Alternative Livelihood Boosted By Economic Opportunities and Rising Global Demand
5.2.1.4 Increasing Applications of Commercial Seaweeds
5.2.2 Restraints
5.2.2.1 Excessive Use of Seaweed Products
5.2.3 Opportunities
5.2.3.1 Increase in Technological Development to Cultivate Seaweed Would Reduce Labor Engagement
5.2.3.2 Seaweed-Emerging as A Snack
5.2.4 Challenges
5.2.4.1 Lack in Financial Support and Government Engagement and Improper Marine Spatial Plans
5.2.4.2 Occurrence of Natural Calamities Resulting in A Decline in the Production of Seaweeds
5.3 Value Chain
5.4 Trade Data
5.4.1 Major Commercial Seaweed Importing Countries
5.4.2 Major Commercial Seaweed Exporting Countries

*6 Commercial Seaweeds Market, By Type*
6.1 Introduction
6.2 Red Seaweeds
6.2.1 Red Seaweeds are Largely Used in Various Food Products Such as Soups, Salads, Snacks, and Sushi
6.3 Brown Seaweeds
6.3.1 Brown Seaweeds are Highly Used in the Production of High-Grade Alginates
6.4 Green Seaweeds
6.4.1 Emerging Uses of Green Seaweed in Other Application Areas Such as Biofuel Production and Wastewater Treatment is Expected to Drive the Market Growth

*7 Commercial Seaweeds Market, By Method of Harvesting*
7.1 Introduction
7.2 Aquaculture
7.2.1 Rise in Demand as A Raw Material for the Hydrocolloid Industry, Such as Carrageenan, Agar-Agar, and Alginates, is Expected to Drive the Growth of Aquaculture Seaweeds
7.3 Wild Harvesting
7.3.1 Growth of Wild Harvesting Seaweeds is Declining, as These Seaweeds are Susceptible to Easy Contamination By Heavy Metals Such as Mercury and Arsenic, Which are Harmful for Human Consumption

*8 Commercial Seaweeds Market, By Form*
8.1 Introduction
8.2 Liquid
8.2.1 Liquid Segment Dominates the Commercial Seaweeds Market Due to Their Varied Applications in Agriculture, Pharmaceuticals, Cosmetics, Animal Feed, and Others
8.3 Powder
8.3.1 Use of the Powdered Form of Seaweeds is Projected to Grow Due to Presence of Vitamin B12 and Vitamin E, Making Them Suitable for Cosmetic Products
8.4 Flakes
8.4.1 Increase in Usage as A Seasoning Agents is Expected to Drive the Segment

*9 Commercial Seaweeds Market, By Application*
9.1 Introduction
9.2 Food
9.2.1 Increasing Industrial Application of Seaweeds Extract Such as Agar, Carrageenan and Alginate in Processed Food is Driving the Market
9.2.2 Dairy Products
9.2.3 Meat & Poultry Products
9.2.4 Bakery Products
9.2.5 Confectionery Products
9.2.6 Others
9.3 Feed
9.3.1 Seaweeds are Significantly Used as Source of Feed Due Their High Protein Content
9.4 Agriculture
9.4.1 Presence of Hormone Such as Auxins & Gibberellins in Seaweeds is Driving the Market for Seaweeds as Agricultural Fertilizers
9.5 Others
9.5.1 Increasing Usage of Seaweeds in Cosmetics, Pharmaceuticals and Bio-Fuel Due to High Nutrient Content is Expected to Drive the Market

*10 Commercial Seaweeds Market, By Region*
10.1 Introduction
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Easy Availability of Raw Materials, Increase in Use of Organic Products, and Growth in the Aquaculture Industry are Propelling the Market for Commercial Seaweeds in China
10.2.2 Indonesia
10.2.2.1 Increase in Usage of Seaweeds as Direct Food Products, and Use of Eucheuma Cottonii Or Gracilaria Into Various Food Products Such as Beverages, Noodles, Cookies, Crackers, and Sweets, Among Others are Expected to Drive the Market
10.2.3 Philippines
10.2.3.1 Multiple Usage of Seaweeds is Expected to Drive the Growth
10.2.4 South Korea
10.2.4.1 South Korea is the The Second-Fastest-Growing Country-Level Market for Commercial Seaweeds in the Asia Pacific Region
10.2.5 Japan
10.2.5.1 Seaweeds are A Traditional Food Product in Japan, is Expected to Augment the Market Growth and Demand
10.2.6 Rest of Asia Pacific
10.3 North America
10.3.1 US
10.3.1.1 Seaweeds are Largely Used in Dairy Products, Which Drives the Demand for Commercial Seaweeds in Us
10.3.2 Canada
10.3.2.1 Seaweeds in Canada are Largely Used as Biostimulant Extracts for Crops as Well as Feed Supplements
10.3.3 Mexico
10.3.3.1 The Demand for Carrageenan in Mexico is Increasing Due to Its Usage in Bakery, Dairy, and Confectionery Segments is Expected to Drive the Growth of Commercial Seaweeds Market
10.4 Europe
10.4.1 France
10.4.1.1 The Use of Seaweeds in the Processed Food Segment and Confectionery Segment Fueled the Growth of the Commercial Seaweeds Market in France
10.4.2 Ireland
10.4.2.1 Ireland Accounted for the Second-Largest Market Size in the Commercial Seaweeds Market in Europe
10.4.3 Norway
10.4.3.1 Growing Industrial & Human Food Application of Seaweeds Drive the Growth of the Commercial Seaweeds Market in Norway
10.4.4 Spain
10.4.4.1 The Trend of Consuming Seaweed as Vegetables is Growing Rapidly in Spain
10.4.5 Rest of Europe
10.5 Rest of the World (RoW)
10.5.1 Brazil
10.5.1.1 Brazil Dominates the Commercial Seaweeds Market in RoW Region
10.5.2 Argentina
10.5.2.1 The R&D for New Cultivation Techniques and Demand for Seaweeds for the Production of Hydrocolloids is Driving the Market in Argentina
10.5.3 South Africa
10.5.3.1 Seaweeds are Widely Used in Generating Biomass for Biofuel Production in South Africa
10.5.4 Others in RoW

*11 Competitive Landscape*
11.1 Overview
11.2 Competitive Scenario
11.3 Market Share Analysis
11.4 Expansions & Investments
11.5 Acquisitions
11.6 New Product Launches
11.7 Partnerships & Agreements

*12 Company Profiles*
12.1 DowDuPont
12.2 Cargill
12.3 Roullier Group
12.4 COMPO EXPERT
12.5 Biostadt India
12.6 CP Kelco
12.7 BRANDT
12.8 Acadian Seaplants
12.9 Gelymar
12.10 Seasol International
12.11 Algea
12.12 Algaia
12.13 CEAMSA
12.14 Seawin BiotechFor more information about this report visit https://www.researchandmarkets.com/research/qqtb6m/global_commercial?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Fruit and Vegetables Reported by GlobeNewswire 18 hours ago.

Dublin, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The "Connected Ship Market by Application (Vessel Traffic Management, Fleet operations, Fleet Health Operations), Installation Type (Onboard, Onshore), Ship Type (Commercial, Defense), Fit (Linefit, Retrofit), Region - Global Forecast to 2023" report has been added to *ResearchAndMarkets.com's* offering.The connected ship market is projected to grow from USD 5.92 billion in 2018 to USD 7.19 billion by 2023, at a CAGR of 3.95% from 2018 to 2023.The key factors fueling the growth of the connected ship market are the incorporation of the Information and Communication Technology (ICT) in the global marine industry, increased budgets of shipping companies for digitalization of their vessels, growth of the seaborne trade across the globe, need for situational awareness among fleet operators, and growth of the maritime tourism industry. However, high costs of marine broadband connectivity and the vulnerability of connected ships to cyber threats due to their digitalization are expected to restrain the growth of the connected ship market across the globe.

*The fleet health monitoring segment of the connected ship market is projected to grow at the highest CAGR during the forecast period.*

Based on application, the connected ship market has been segmented into fleet operations, fleet health monitoring, and vessel traffic management. The fleet health monitoring segment is projected to grow at the highest CAGR from 2018 to 2023. The requirement for real-time connectivity in marine ships is expected to fuel the growth of the fleet health monitoring segment of the market during the forecast period. Fleet health monitoring increases the lifespan of fleets and reduces their maintenance costs. The data acquired from sensors installed on marine vessels is transmitted to onshore stations by vessel operators for analysis to avoid component and machinery failures in them.

*The onboard segment of the connected ship market is projected to grow at a higher CAGR than the onshore segment from 2018 to 2023.*

Based on installation type, the onboard segment of the connected ship market is projected to grow at a higher CAGR than the onshore segment during the forecast period. Increased demand for modernizing the existing connectivity systems of ships is expected to fuel the growth of the onboard segment of the market. The growth of the global cruise industry, owing to an increase in the number of passengers traveling by cruises, worldwide is also fueling the growth of the onboard segment of the market.

*The European region is projected to lead the connected ship market during the forecast period.*

The European region is projected to lead the connected ship market from 2018 to 2023. The Europe connected ship market is also projected to grow at the highest CAGR during the forecast period. Although the shipbuilding industry in the region is going through a rough patch at present, the increased demand for autonomous ships and cruises from the region is expected to fuel the growth of the Europe connected ship market. The European region is one of the prime consumers of marine electronic equipment as some of the leading shipbuilding countries such as Germany, France, Italy, and Russia are in this region.

The key players profiled in the connected ship market report include Northrop Grumman (US), General Electric (US), Wartsila (Finland), Kongsberg Grumman (Norway), and Marlink (Norway), among others.

*Key Topics Covered:**1 Introduction*
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.4 Currency & Pricing
1.5 Study Limitations
1.6 Stakeholders

*2 Research Methodology*
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Research Assumptions

*3 Executive Summary *

*4 Premium Insights*
4.1 Attractive Opportunities in Connected Ship Market
4.2 Connected Ship Market, By Ship Type
4.3 Europe Connected Ship Market, By Country & Application
4.4 Connected Ship Market, By Installation Type
4.5 Connected Ship Market, By Fit
4.6 Connected Ship Market, By Region

*5 Market Overview*
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Incorporation of ICT in the Global Marine Industry
5.2.1.2 Increased Budgets of Shipping Companies for Digitalization of Vessels
5.2.1.3 Increase in Seaborne Trade Across the Globe
5.2.1.4 Situational Awareness Requirement of Fleet Operators
5.2.1.5 Growing Maritime Tourism Industry
5.2.2 Restraints
5.2.2.1 High Costs of Marine Broadband Connectivity
5.2.2.2 Digitalization Renders Connected Ships Vulnerable to Cyber Threats
5.2.3 Opportunities
5.2.3.1 Initiatives for the Development of Connected Autonomous Ships
5.2.3.2 Adoption of Vessel Traffic Services (VTS) By Shipping Companies
5.2.3.3 Development of New Port Cities in Emerging Economies
5.2.4 Challenges
5.2.4.1 Limited Internet Facilities in Connected Ships
5.2.4.2 Lack of Skilled Personnel to Handle and Operate Connected Ships
5.2.4.3 Lack of Common Standards for Data Generated From Different Subsystems of Connected Ships

*6 Industry Trends*
6.1 Introduction
6.2 Technology Roadmap
6.3 Technological Advancements in the Marine Industry
6.3.1 Artificial Intelligence
6.3.2 Big Data Analytics
6.3.3 Internet of Things (IoT)
6.3.4 Cloud-Based Solutions
6.3.5 Smart Ships Using Satellite Communication
6.4 Technology Trends
6.4.1 Global Navigation Satellite System (GNSS)
6.4.2 High Throughput Satellites (HTS)
6.4.3 Digital Marine Automation Systems
6.4.3.1 Sensor Fusion Solutions
6.4.3.2 Control Algorithms
6.4.3.3 Conning Systems
6.4.3.4 Connectivity Solutions
6.4.3.5 Autopilot
6.4.3.6 Mooring Control and Monitoring Systems
6.4.3.7 Automated Radar Plotting Aid
6.4.3.8 Electronic Chart Display and Information System
6.4.3.9 Communication Systems
6.4.3.10 Voyage Data Recorders
6.4.3.11 Decision Support Systems
6.4.4 Vessel Traffic Management System
6.4.5 Autonomous Marine Vessels
6.4.6 Integrated Ship Automation Systems

*7 Connected Ship Market, By Application*
7.1 Introduction
7.2 Vessel Traffic Management
7.2.1 Demand for Safety and Efficiency of Vessels Will Drive the Growth for Vessel Traffic Management Systems
7.3 Fleet Operations
7.3.1 Need for Real-Time Situational Awareness to Fleet Operators Will Boost Demand for Fleet Operations
7.4 Fleet Health Monitoring
7.4.1 Increasing Demand for Remote Engine Monitoring System for Marine Engines to Drive the Growth of Fleet Health Monitoring System

*8 Connected Ship Market, By Installation Type*
8.1 Introduction
8.2 Onboard
8.2.1 Navigation Positioning and Tracking
8.2.1.1 Integrated Bridge Systems
8.2.1.1.1 Increasing Use of Connectivity Solutions in the Integrated Bridge System is Driving the Growth of the Market
8.2.1.2 Navigation Systems
8.2.1.2.1 Need for Efficient Route Planning for Ships Will Boost Demand for Navigation Systems
8.2.2 Ship Information Management Systems
8.2.2.1 Voyage Data Recorders
8.2.2.1.1 Installation of Sensors in Vessel Systems Will Boost Demand for Voyage Data Recorders
8.2.2.2 Data Processors
8.2.2.2.1 Growing Demand for Big Data Analytics is Driving the Growth of Data Processors in the Market
8.2.3 Communication Management Systems
8.2.3.1 Very Small Aperture Terminal
8.2.3.1.1 Rise in the Use of Satellite Connectivity is Driving the Growth of Vsat
8.2.3.2 Mobile Satellite Systems
8.2.3.2.1 Deliveries of Mobile Satellite Devices for Marine Application Expected to Push the Demand for Mss
8.2.4 Automation
8.2.4.1 Surveillance and Safety Systems
8.2.4.1.1 Ensuring Safe and Secure Navigation of Ships Will Boost Demand for Surveillance and Safety
8.2.4.2 Power Management Systems
8.2.4.2.1 Importance of Continuing Power Supply in Vessels is Supporting the Growth of Pms
8.2.4.3 Propulsion Control Systems
8.2.4.3.1 Optimum Performance of Propulsion Systems is Driving the Demand for Propulsion Control System
8.2.4.4 Machinery Management Systems
8.2.4.4.1 Importance of Monitoring Health and Functions of Vessel Systems is Driving the Growth of the Machinery Management Systems
8.2.4.5 Alarm Management Systems
8.2.4.5.1 Controlling Faulty Alarm System and Preventing Critical System Failure Supports the Growth of the Segment
8.2.4.6 Ballast Management Systems
8.2.4.6.1 Strict Regulations to Treat Ballast Water in Ships is Driving the Growth of Ballast Management
8.2.4.7 Thruster Control Systems
8.2.4.7.1 Enhancing Easy Maneuvering of Ship is Driving the Demand for Thruster Control Systems
8.3 Onshore
8.3.1 Servers
8.3.1.1 Asia Pacific to Lead Connected Ship Market for Onshore Servers Between 2018 to 2023
8.3.2 Ship Data Analysis and Management
8.3.2.1 Software
8.3.2.1.1 Fleet Management Software
8.3.2.1.1.1 Increase in Marine Vessel Deliveries Will Boost Demand for Fleet Management Software
8.3.2.1.2 Data Analysis Software
8.3.2.1.2.1 IoT Based Sensors and Alarm Monitoring Sensors are Supporting the Growth of Data Analysis Software
8.3.2.2 Services
8.3.2.2.1 Health Monitoring Services
8.3.2.2.1.1 Increasing Awareness of Predictive Maintenance in Ships to Drive the Demand for Health Monitoring Services
8.3.2.2.2 Navigation Assistance Services
8.3.2.2.2.1 Smooth and Effective Navigation of Marine Vessels Will Boost Demand for Navigation Assistance Services

*9 Connected Ship Market, By Ship Type*
9.1 Introduction
9.2 Commercial
9.2.1 Passenger Ships & Cruises
9.2.1.1 Growth in International Sea Travel Will Boost Demand in Passenger Ships & Cruises
9.2.2 Dry Cargos
9.2.2.1 Upgradation in the Dry Cargos for Real Time Data Exchange is Driving the Growth
9.2.3 Other Ships
9.2.3.1 Specialized Vessels
9.2.3.1.1 High Demand for Specialized Vessels in Maritime Tourism is Supporting the Growth in the Market
9.2.3.2 Offshore Vessels
9.2.3.2.1 Demand From Oil and Gas Industry is Driving the Growth of Offshore Vessels
9.3 Defense
9.3.1 Aircraft Carrier
9.3.1.1 Upgradation of Communication Devices is Driving the Growth in Aircraft Carrier
9.3.2 Corvettes
9.3.2.1 Rise in Situational Awareness to Drive the Demand in Corvettes
9.3.3 Frigates
9.3.3.1 Improvising the Co-Ordination in the Naval Fleet is Driving the Growth in Frigates
9.3.4 Submarine & Uuvs
9.3.4.1 Growing Applications of Unmanned and Underwater Ships are Driving the Demand in Submarines & Uuvs

*10 Connected Ship Market, By Fit*
10.1 Introduction
10.2 Linefit
10.2.1 Increase in the Deliveries of New Ship is Expected to Drive the Demand in Linefit Segment
10.3 Retrofit
10.3.1 Rise in the Upgradation of Connected Systems for Older Vessels is Expected to Drive the Demand in Retrofit Segment

*11 Regional Analysis*
11.1 Introduction
11.2 Asia Pacific
11.2.1 By Country
11.2.1.1 China
11.2.1.1.1 Increase in Naval Spending and Rise in Domestic Ship Production are Expected to Drive the Connected Ship Market in China
11.2.1.2 South Korea
11.2.1.2.1 Integration of Connected Ship System By Various Shipbuilding Players to Drive the Growth in South Korea
11.2.1.3 Japan
11.2.1.3.1 Increasing Deliveries of Naval Ship is Driving the Growth of Connected Ship Market in Japan
11.2.1.4 India
11.2.1.4.1 Upgradation of Old Ships With New Systems is Expected to Drive the Market in India
11.2.1.5 Rest of Asia Pacific
11.2.1.5.1 Demand for Upgradation of Legacy System to Boost the Demand for Connected Ship Systems in the Region
11.3 North America
11.3.1 By Country
11.3.1.1 US
11.3.1.1.1 Rise in Naval Ship Building in the Country is Driving the Growth of the Market
11.3.1.2 Canada
11.3.1.2.1 Canada Government's Strategic Decision to Develop Its Own Indigenous Marine Industry to Grow the Market
11.4 Europe
11.4.1 By Country
11.4.1.1 Germany
11.4.1.1.1 Ship Equipment Upgradation Will Boost the Demand for Connected Ship Systems in the Country
11.4.1.2 Italy
11.4.1.2.1 Retrofitting of Connected Ship Technologies in Vessels is Driving the Growth of the Market in Italy
11.4.1.3 UK
11.4.1.3.1 Growing Investment in the Upgradation of Marine System is Expected to Drive the Connected Ship Market in UK
11.4.1.4 Russia
11.4.1.4.1 Introduction of Automation Technologies in Naval Ships Will Boost Demand for Connected Systems in Russia
11.4.1.5 France
11.4.1.5.1 Increasing Development of Naval Vessels has Contributed to the Growth of the Connected Ship Market in France
11.4.1.6 Rest of Europe
11.4.1.6.1 Supply of Connected Ship Components and Systems From OEMs to Drive the Growth of the Market
11.5 Rest of the World
11.5.1 By Region
11.5.1.1 Middle East & Africa
11.5.1.1.1 Development of National Shipbuilding Companies Have Provided Momentum to the Shipbuilding Industry
11.5.1.2 Latin America
11.5.1.2.1 Rise in the Maritime Trade and Ship Overhauling is Driving the Demand for Connected Ship Market

*12 Competitive Landscape*
12.1 Introduction
12.2 Rank Analysis of Companies in Connected Ship Market, 2017
12.3 Regional Mapping of Leading Companies in Connected Ship Market
12.4 Competitive Scenario
12.4.1 Contracts
12.4.2 New Product Launches
12.4.3 Acquisitions
12.4.4 Agreements, Partnerships, and Collaborations

*13 Company Profiles*
13.1 ABB
13.2 Emerson
13.3 General Electric (GE)
13.4 Hyundai Heavy Industries (HHI)
13.5 Jason
13.6 Kongsberg Gruppen
13.7 Marlink
13.8 Northrop Grumman
13.9 RH Marine
13.10 Rockwell Automation
13.11 Schneider Electric
13.12 Siemens
13.13 Ulstein
13.14 Valmet
13.15 Wartsila
13.16 Innovators
13.16.1 Iridium
13.16.2 Inmarsat
13.16.3 Viasat
13.16.4 IntelsatFor more information about this report visit https://www.researchandmarkets.com/research/qdw5dz/connected_ship?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Maritime Reported by GlobeNewswire 18 hours ago.

Reported by SeekingAlpha 17 hours ago.

Ship traffic Due to arrive today SHIP FROM PORT ANL Warrnambool Tauranga, New Zealand OAK Atlantic Highway Long Beach BNC CAP Palmerston Long Beach OAK Hyundai Tokyo Long Beach OAK MSC Beryl Long Beach OAK MSC Branka Long Beach OAK NYK Argus Los Angeles OAK President Cleveland Los Angeles OAK Due to depart today SHIP TO PORT ANL Walwa Long Beach OAK Delphinus Leader Port Hueneme, L.A. County RCH Henry Hudson Bridge Tokyo SFO Matsonia Honolulu OAK MSC Branka Vancouver, B.C. OAK NYK Adonis Xingang, China SFO Rockies Highway Irago, Japan BNC Source: S.F. Marine Exchange Reported by SFGate 16 hours ago.

OLDWICK, N.J.--(BUSINESS WIRE)--A.M. Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a-” of New York Marine and General Insurance Company (New York, NY) and its wholly owned subsidiaries, Gotham Insurance Company (New York, NY) and Southwest Marine & General Insurance Company (Scottsdale, AZ) (collectively referred to as ProSight Specialty Group). The outlook of these Credit Ratings (ratings) is stable. Conc Reported by Business Wire 15 hours ago.

The Indian Navy's former flagship INS Viraat may soon find itself in a new avatar on Maharashtra's coastline, making it India's first decommissioned aircraft carrier to be converted into a maritime and adventure tourism destination.

On Thursday, the state cabinet approved a proposal to convert the INS Viraat, Indian navy's former flagship ship--which holds the distinction of being the world's longest-serving warship--into a museum on a PPP basis in an around Rs 852 crore project. It will be grouted around 7 nautical miles in the sea at Nivati rocks in Sindhudurg, where visitors will also be able to view the unique marine eco-system.

An official said the private partner would conserve the ship and use it for activities like a maritime museum, virtual galleries, cafeteria, marine bio-diversity centre, adventure sports like sailing and scuba-diving and training of merchant navy crew.
                                   
The private partner may also be able to develop it as a comprehensive tourism destination including a helipad, convention centre and luxury accommodation, which must confirm with "the dignity of the ship," he added.

The Indian Navy's first aircraft carrier, the INS Vikrant was decommissioned in 1997 and its conversion to a full-time museum ship fell through due to reasons like funding. The Majestic-class aircraft carrier, which was used by both, the Royal and Indian Navies, was finally scrapped in 2014, leading to condemnation from former Navy personnel and enthusiasts.

Globally, around seven aircraft carriers have been converted to museum ships and exhibits or theme parks and luxury hotels including USS Hornet, USS Intrepid, USS Lexington, USS Midway, USS Yorktown (United States) and Minsk and Kiev (China).

Originally commissioned into the British Royal Navy as HMS Hermes in 1959, the ship saw action in the 1982 Falklands War. The Centaur-class aircraft carrier spent 27 years in the Royal Navy and was commissioned into the Indian Navy on May 12, 1987. It was decommissioned in 2017 and is docked in Mumbai's Naval dockyard.

"Any company (private party) will pick it up and try to convert it into a museum, convention centre, and for adventure sports," said Vikram Kumar, chief executive officer (CEO), Maharashtra Maritime Board (MMB).

The state feels the location near Vengurla will serve as a magnet for domestic and international tourists considering its proximity to Goa and the Greenfield airport at nearby Parule- Chipi.

A former Indian Navy official said the conservation of the ship would lead to it being shifted away from the Mumbai docks, where it is taking up precious space meant for the Navy's vessels.

-*About INS Viraat*-

Part of India's rich maritime heritage, INS Viraat holds the world record of being the longest serving warship.

Under the Indian flag, the ship clocked over 22,622 flying hours and spent nearly 2,252 days at sea sailing across 5,88,287 nautical miles (10,94,215 KM).

Viraat played a major role in Operation Jupiter in 1989 during the Sri Lankan Peacekeeping operation, Op Parakram (2001-2002) and operational deployments and international joint exercises.

The ship was decommissioned on March 6, 2017

(Source: Indian Navy)

Article Type: 
Report
Sections: 
Mumbai
India
Authors: 
Dhaval Kulkarni
Agencies: 
DNA
Cities: 
Mumbai
Tags: 
Indian Navy
INS Viraat
tourism destinations
museum
Maharashtra Maritime Board
Nivati rocks
Sindhudurg
Aircraft Carrier
USS Hornet
USS Intrepid
USS Lexington
USS Midway
USS Yorktown
Minsk
KIEV
Vikram Kumar
Fri, 2 Nov 2018-05:15am
Date updated: 
Friday, 2 November 2018 - 5:15am
Article Images: 
DNA
Short URL: 
dnai.in/fKez
Embargo: 
Syndicate: 
Hide lead image: 
Page views: 
1
From Print Edition: 
Highlights:  Reported by DNA 10 hours ago.

KEMP, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Larson Electronics LLC, Leader in industrial and explosion proof equipment, has released an adjustable propane convection heater capable of operating without electricity, ideal for heating indoor facilities up to 2,000 square feet. This heater offers three BTU options: 60K, 70K and 80K and comes with a 10-foot LP cylinder hose regulator.The Larson Electronics GAU-GCH-FM-80K is an adjustable propane heater for indoor locations that does not require electricity to operate. This compact heater can heat spaces up to 2,000 square feet with a 360-degree radius and has an adjustable output setting. Operators may choose from 60,000, 70,000, or 80,000 BTUs. This unit consumes propane at a rate of 2.8 pounds/ 3.2 pounds/3.7 pounds per hour depending on BTUs and is capable of a maximum runtime of 36 hours at full tank on 60,000 BTUs.

The GAU-GCH-FM-80K includes a 10-foot LP cylinder hose and regulator that attaches to the supply valve of the propane tank. The tank has a setting dial to control BTUs. This unit includes a special 2-piece burn chamber and an inner wind guard, as well as safety features including: tip-over shut off, high temperature shut off, flame out fuel cut, guards and thermocouple. The GAU-GCH-FM-80K weighs just 15 pounds and is mounted onto a flat base for surface mounting.

“This compact heater offers comprehensive and effective heating for indoor locations like warehouses, barns or industrial sites,” said Rob Bresnahan, CEO of Larson Electronics LLC. “This heater is nice because it’s adjustable, so users can control heat output and doesn’t require any electricity to operate.”

*About Larson Electronics LLC:* Larson Electronics LLC is a manufacturer of industrial lighting equipment and accessories. The company offers an extensive catalog of industry-grade lighting and power distribution products for the following sectors: manufacturing, construction, food processing, oil and gas, military, marine and automobile. Customers can benefit from the company’s hands-on, customized approach to lighting solutions. Larson Electronics provides expedited service for quotes, customer support and shipments.

*For further information, please contact:*
Rob Bresnahan, *President and CEO
*Toll-free: 1-800-369-6671
Phone: 214-616-6180
Fax: 903-498-3364
E-mail: sales@larsonelectronics.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9e324759-af03-47b3-9530-f825d35cc136

  Reported by GlobeNewswire 14 hours ago.

Frontline Ltd. (the "Company" or "Frontline") (NYSE: FRO) today announces that it has ordered exhaust gas cleaning systems ("EGCS") for a further 12 vessels from Feen Marine Scrubbers Inc. ("FMSI").  This follows the Company's previously announced commitment to order six EGCS with additional fixed price options from FMSI and its acquisition of a 20% ownership interest in FMSI in June 2018. In total, Frontline has thus far committed to install 20 EGCS, including two EGCS being installed on the newbuilding VLCCs Front Discovery and Front Defender.

In addition, Frontline announces that it has extended the terms of its senior unsecured revolving credit facility of up to $275.0 million with an affiliate of Hemen Holding Ltd. by 12 months to November 2020.

Robert Hvide Macleod, CEO of Frontline Management said:

"Backed by the ongoing commitment and support from Frontline's largest shareholder, we have taken significant steps to modernize our fleet, decreasing the average age of our owned vessels to 4.7 years.  Following the committed installations, over 40% of our owned fleet will be equipped with scrubbers.  Notably, the majority of these installations will be performed prior to 2020, when new sulphur emissions compliance requirements go into effect.  Further installations will be considered, and we are uniquely positioned to access scrubber capacity from Feen Marine.  We believe our actions will position the Company to generate significant earnings for our shareholders."

Lastly, Frontline announces that 180,000 share options have been awarded to employees in accordance with the terms of the Company's Share Option Scheme. The share options will expire in July 2021 and will vest in July 2019. The exercise price is USD 7.40. The exercise price will be adjusted for any distribution of dividends made before the relevant options are exercised. Out of the total number of share options 10,000 have been awarded to the primary insider Tom Pryor (CAO) according to the above and following this he has 10,000 share options and no shares in the Company.

November 1, 2018
The Board of Directors
Frontline Ltd.
Hamilton, Bermuda

Robert Hvide Macleod: Chief Executive Officer, Frontline Management AS
+47 23 11 40 84

Inger M. Klemp: Chief Financial Officer, Frontline Management AS
+47 23 11 40 76

Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. Words, such as, but not limited to "believe,""anticipate,""intends,""estimate,""forecast,""project,""plan,""potential,""may,""should,""expect,""pending" and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Frontline believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond the control of Frontline, Frontline cannot assure you that they will achieve or accomplish these expectations, beliefs or projections. The information set forth herein speaks only as of the date hereof, and Frontline disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.

This information is subject to the disclosure requirements pursuant to section 5-12 and section 4-2 of the Norwegian Securities Trading Act. Reported by GlobeNewswire 14 hours ago.